10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2025

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number: 333-290920

Aeon Acquisition I Corp.

(Exact name of registrant as specified in its charter)

Cayman Islands	N/A
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

66 West Flagler Street, Suite 900 Miami, FL	33130
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (212) 621-8777 

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: None.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of June 30, 2025, the aggregate market value of the registrant’s ordinary shares held by non-affiliates of the registrant was $0.

As of April 14, 2026, there were 0 Class A Ordinary Shares, par value $0.0001 per share, and 12,321,429 Class B Ordinary Shares, par value $0.0001 per share, of the registrant issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

None.

Aeon Acquisition I Corp.

FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025

TABLE OF CONTENTS

		PAGE
PART I		1
Item 1.	Business.	1
Item 1A.	Risk Factors.	3
Item 1B.	Unresolved Staff Comments.	3
Item 1C.	Cybersecurity.	3
Item 2.	Properties.	3
Item 3.	Legal Proceedings.	3
Item 4.	Mine Safety Disclosures.	3
PART II		4
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.	4
Item 6.	[Reserved]	4
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	4
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk.	5
Item 8.	Financial Statements and Supplementary Data.	5
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.	5
Item 9A.	Controls and Procedures.	5
Item 9B.	Other Information.	6
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.	6
PART III		7
Item 10.	Directors, Executive Officers and Corporate Governance.	7
Item 11.	Executive Compensation.	8
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.	8
Item 13.	Certain Relationships and Related Transactions, and Director Independence.	9
Item 14.	Principal Accountant Fees and Services.	9
PART IV		10
Item 15.	Exhibit and Financial Statement Schedules.	10
Item 16.	Form 10-K Summary.	11
SIGNATURES		12

i

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. The statements contained in this Report that are not purely historical are forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipates,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws and/or if and when management knows or has a reasonable basis on which to conclude that previously disclosed projections are no longer reasonably attainable.

Unless otherwise stated in this Report, or the context otherwise requires, references to:

● “Amended and Restated Articles” are to our Amended and Restated Memorandum and Articles of Association, as currently in effect;

● “Business Combination” are to a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses;

● “Certifying Officers” are to our Chief Executive Officer and Chief Financial Officer, together;

● “Class A Ordinary Shares” are to our Class A ordinary shares, par value $0.0001 per share;

● “Class B Ordinary Shares” are to our Class B ordinary shares, par value $0.0001 per share;

● “Companies Act” are to the Companies Act (As Revised) of the Cayman Islands, as may be amended from time to time;

● “Company,” “our,” “we,” or “us” are to Aeon Acquisition I Corp., a Cayman Islands exempted company;

● “Exchange Act” are to the Securities Exchange Act of 1934, as amended;

● “GAAP” are to the accounting principles generally accepted in the United States of America;

● “JOBS Act” are to the Jumpstart Our Business Startups Act of 2012;

● “Management” or our “Management Team” are to our executive officers and our director;

● “Ordinary Shares” are to the Class A Ordinary Shares and the Class B Ordinary Shares, together;

● “PCAOB” are to the Public Company Accounting Oversight Board (United States);

● “Report” are to this Annual Report on Form 10-K for the fiscal year ended December 31, 2025;

● “Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002, as amended;

● “SEC” are to the U.S. Securities and Exchange Commission;

● “Securities Act” are to the Securities Act of 1933, as amended;

● “Sponsor” are to Aeon Acquisition Partners I LLC, a Delaware limited liability company;

ii

PART I

ITEM 1. BUSINESS

Overview

We are a blank check company incorporated on August 1, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination with one or more businesses or entities. As of the date of this Report, we have not selected any specific Business Combination target. We have generated no operating revenues to date.

Our Management Team

Our management team has extensive experience in mergers and acquisitions, capital markets, private equity, and operating businesses globally.

Executive Officers and Directors

Mr. Demetrios Mallios has served as our Chief Executive Officer and director since August 2025. Mr. Mallios is the Founder of The Aeon Group, Inc., the parent company of the Aeon Family of Funds and AeonX, as well as other subsidiaries, and has held the position of Chief Executive Officer since July 2013. Mr. Mallios has had a diverse career over the past 30+ years as a fund manager, corporate consultant, investment banker, executive and entrepreneur. Prior to Aeon, his experience as Partner, CEO, COO, and Head of Investment Banking at many firms in the US, China as well as other countries has allowed him to participate as principal investor and/or agent in primary and secondary transactions in private and public companies worldwide. He has served as a director of Invent Ventures, Inc. (OTC: IDEA), a technology venture firm, since November 2017. Mr. Mallios has previous experience also includes Bank of America, UBS, Paulson Investment Company, and Jensyn Acquisition Corp. See “Prior Blank Check Experience.”

Mr. Alan Lewis, has served as our Chief Financial Officer since October 2025. Mr. Lewis has a track record of success as a transformational leader in the financial, investment, and technology industries. He has co-founded and raised funds for multiple ventures, including The Aeon Group, Inc. In his current roles and as an investment banker, Alan has leveraged his extensive background in entrepreneurship, start-ups, mergers & acquisitions, due diligence, strategy, venture capital, corporate finance, private equity, and strategic planning to help companies innovate in the digital arena at firms. He co-founded The Aeon Group, Inc. and since March 2014 has served as Chief Strategy Officer and a director. Since, June 2004, he has been the Managing Member of Aeon X, LLC, a technology platform that offers access to a collection of alternative investments and related products. He received his Bachelor of Arts degree in Political Science from American Public University in 2011 and a Masters of Public Administration in Organizational Leadership from CSU Northridge in 2012. He has also demonstrated the ability to grow private equity and venture capital funds and is dedicated to continuous learning in the rapidly evolving digital landscape, as demonstrated by his pursuit of a doctoral degree in Education and Psychology from Pepperdine University.

Mr. Victor (Rock) Klinefelter, has served as our Chief Operating Officer since October 2025. Mr. Klinefelter brings nearly 30 years of senior management experience across privately held, publicly traded, and Fortune 100 companies such as Leo Burnett, Diesel, and Philip Morris International. He has held national, regional, and global leadership roles in the USA, Asia, and Europe—successfully guiding diverse, multicultural teams through periods of growth and expansion. He began his career at the Leo Burnett Company, where he rose to the role of Global Director. He later served as Global Head of Marketing at Diesel, Regional Marketing Director Asia at Philip Morris International, and Global Commercial Director for Philip Morris International Duty Free. Following these corporate roles, he co-founded a business development venture and currently serves as Chief Operating Officer and Chief of Staff at The Aeon Group. Mr. Klinefelter is a graduate of Amherst College (Massachusetts, USA).

Mr. Georgios Panou has served as our Chief Investment Officer since October 2025. Mr. Panou is a seasoned sports-marketing executive who has co-led Octagon Basketball Europe since 2016, growing it into the continent’s second-largest basketball agency. In May 2022, he founded Upgr8 Sports Management Ltd., building partnerships with Olympic athletes and global brands (VISA, L’Oréal, Allianz, PlayStation) and also co-established Octagon International Soccer, where he orchestrated record-breaking transfers. Since March 2022, Mr. Panou has served as director of OIS Agency Ltd, a soccer focused sports agency. A former national-team coach who led Greece to a World Cup silver in 2006, Georgios holds a degree in Sports Training & Sports Marketing from Visa Skola in Belgrade in 2001.

Mr. Alex Saratsis has served as our Chief Strategy Officer since October 2025. Mr. Saratsis is Co-Managing Director of Octagon Basketball, where since 2020 he has co-led a global division representing 40+ NBA stars and overseeing over $2 billion in active contracts and endorsements. With two decades of international sports-management experience, Alex built Octagon’s basketball operations across North America, Europe, Asia, and South America—recruiting elite talent, negotiating landmark deals (including Giannis Antetokounmpo’s record extensions), and launching Octagon54 to develop African basketball prospects. A Northwestern graduate with a Bachelor’s Degree in Political Scient in May 2002, fluent in four languages, Alex also teaches Sports Administration at his alma mater.

Mr. Themis Bilionis has served as our Chief Business Officer since October 2025. Mr. Bilionis, born in Athens in 1977, has extensive operational expertise in European sports management. After starting his career at Basketopolis S.A. as Head of Marketing and Communications, he co-founded the Octagon Basketball Europe network in 2013, later merging to form OBE SPORTS MANAGEMENT LTD in 2020. Since March 2021, Mr. Bilionis has served as Director of Operations of OBE Sports Management LTD, as well as a member of the Board of Directors. Mr. Bilionis received his Bachelor of Arts degree from Panteion University of Social Sciences in 1996 and a Master of Arts degree from University of Durham Business School in 2003.

1

Employees

We currently have 6 officers and do not intend to have any full-time employees prior to the completion of our initial Business Combination. Members of our management team are not obligated to devote any specific number of hours to our matters.

Periodic Reporting and Financial Information

We will be required to evaluate our internal control procedures for the fiscal year ending December 31, 2026 required by the Sarbanes-Oxley Act. Only in the event we are deemed to be a large accelerated filer or an accelerated filer and no longer an emerging growth company will we be required to have our internal control procedures audited. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.

We are a Cayman Islands exempted company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman Islands and, as such, are exempted from complying with certain provisions of the Companies Act. As an exempted company, we have applied for and received a tax exemption undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Act (As Revised) of the Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations will apply to us or our operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable (i) on or in respect of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of us.

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.

We will remain an emerging growth company until the earlier of: (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of our initial public offering, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the aggregate worldwide market value of our Class A ordinary shares that is held by non-affiliates equals or exceeds $700.0 million as of the end of the prior fiscal year’s second fiscal quarter; and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period. References herein to “emerging growth company” will have the meaning associated with it in the JOBS Act.

Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the aggregate worldwide market value of our Class A ordinary shares held by non-affiliates equaled or exceeded $250.0 million as of the end of the prior June 30th, and (2) our annual revenues equaled or exceeded $100.0 million during such completed fiscal year or the aggregate worldwide market value of our Class A ordinary shares held by non-affiliates equaled or exceeded $700.0 million as of the prior June 30th.

2

ITEM 1A. RISK FACTORS

As a smaller reporting company, we are not required to make disclosures under this Item. 

ITEM 1B. UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 1C. CYBER SECURITY

Although, as a blank check company, we do not have any operations, we are nonetheless subject to the risk of cybersecurity incidents. Among other things, our bank deposits may be vulnerable to such incidents, and we may depend on the digital technologies of third parties. We and third parties may be subject to cybersecurity attacks or security breaches. To the extent that we rely on the technologies of third parties, we depend upon the personnel and the processes of such third parties to protect against cybersecurity incidents, and we have no personnel or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, our Management Team will report to the Board of Directors and provide updates on the Management Team’s incident response plan for addressing and mitigating any risks associated with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse consequences on our business and lead to financial loss.

ITEM 2. PROPERTIES

Our executive offices are located at 66 West Flagler Street, Suite 900, Miami, FL 33130, and our telephone number is 877-787-1880. We consider our current office space adequate for our current operations.

ITEM 3. LEGAL PROCEEDINGS

We entered into a Settlement Agreement with respect to an arbitration that was filed against us, Demetrios Mallios, The Aeon Group, Inc. (“AGI”), and Geneships Acquisition Corp. with the American Arbitration Association in February 2026 (AAA Case No. 01-26-0000-6229) by Chardan Capital Markets, LLC (“Chardan”) in connection with fees for certain capital-raising activities, including related to a possible SPAC transaction, under a 2023 engagement letter and 2024 amendment that preceded our formation. The total amount sought was not less than $15,000,000.

In February 2026, we commenced a special proceeding in the Supreme Court of the State of New York (Index No. 65082/2026) seeking to permanently stay the arbitration as against the Company. Demetrios Mallios, our Chairman and Chief Executive Officer, and, his affiliate, The Aeon Group, Inc. jointly and severally indemnified the Company and its shareholders for any liabilities, losses, or expenses arising from the arbitration and any related claims.

On March 20, 2026, the parties agreed to a binding settlement term sheet and on March 26, 2026, the Company entered into a Settlement Agreement (the “Settlement Agreement”) with Chardan, Mr. Mallios, Geneships Acquisition Corp., AGI and D. Boral Capital LLC (“D. Boral”).

The Settlement Agreement is contingent upon the closing of this offering and will become effective only upon the closing of this offering (the “Effective Time”). The Settlement Agreement provides, among other things, that Chardan will serve as lead book-running manager and D. Boral will serve as co-lead book-running manager for this offering and that underwriting compensation in connection with this offering will be allocated between them. The Settlement Agreement further provides that, following the Effective Time, the arbitration and related court proceeding will be dismissed with prejudice, and mutual general releases between us, Demetrios Mallios, Geneships Acquisition Corp., and AGI that are contained in the Settlement Agreement will become effective, pursuant to which each party, on behalf of itself and its affiliates and related parties, will release the other parties and their respective affiliates and representatives from all claims, whether known or unknown, arising out of or relating to events occurring on or prior to March 25, 2026 other than obligations arising under the Settlement Agreement and related transaction documents.

If this offering does not close on or prior to May 25, 2026, unless extended by mutual agreement of the Company, Chardan and D. Boral, the Settlement Agreement will automatically terminate and be of no further force or effect. In such event, the arbitration and related proceedings could continue, and the Company and its affiliates could remain subject to claims in excess of $15,000,000. If the Settlement Agreement does not become effective, the arbitration and related court proceedings would resume, and our ability to complete this offering or any subsequent initial business combination could be materially and adversely affected.

The Settlement Agreement does not affect the funds held in the trust account established in connection with this offering. Other than the deferred underwriting commissions described under “Underwriting,” which are payable from the trust account upon the completion of an initial business combination, no amounts payable under or in connection with the Settlement Agreement will be paid from the trust account. The Company does not expect that any liabilities arising under or in connection with the Settlement Agreement, including any claim for breach thereof, would be payable from the trust account, and the Settlement Agreement provides that neither the Company nor the trust account will be responsible for any payments required to effect the allocation of underwriting compensation between the underwriters. No additional compensation is payable by the Company in connection with the Settlement Agreement other than the underwriting compensation described under “Underwriting.”

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

3

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

There is no current market for our ordinary shares.

Holders of Record

As of April 14, 2026, there were 12,321,429 of our Class B Ordinary Shares issued and outstanding held by 1 stockholder of record.

Dividends

We have not paid any cash dividends on our ordinary shares to date.

Securities Authorized for Issuance Under Equity Compensation Plans

None.

Recent Sales of Unregistered Securities

None.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

Not applicable.

ITEM 6. [RESERVED]

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations and Known Trends or Future Events

We have neither engaged in any operations nor generated any revenues to date. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements.

Liquidity and Capital Resources

Our liquidity needs have been satisfied through $550,000 in promissory notes from our Sponsor ($507,416.31 of which has been drawn down on April 8, 2026).

Settlement Agreement

As described under “Legal Proceedings,” we have entered into a Settlement Agreement to resolve a pending arbitration and related proceedings. The effectiveness of the Settlement Agreement is contingent upon the closing of our potential IPO. If the potential initial public offering is not closed by May 25, 2026 (subject to extension by mutual agreement), the Settlement Agreement will not become effective and the arbitration and related proceedings could continue, and we could remain subject to claims in excess of $15,000,000.

We do not expect any liabilities arising under or in connection with the Settlement Agreement, including any claim for breach thereof, to be payable from the trust account, other than the deferred underwriting commissions described in this prospectus, which are payable from the trust account upon the completion of an initial business combination.

Related Party Transactions

On August 20, 2025, our Sponsor and certain directors and officers, either directly or indirectly, purchased an aggregate of 12,321,429 Class B ordinary shares for an aggregate purchase price of $25,000, or approximately $0.002 per share.

On August 20, 2025, we issued an unsecured promissory note to our sponsor with an aggregate principal amount of up to $200,000, which is non-interest-bearing. We amended and restated such note as of December 30, 2025 to increase the amount to $350,000 and further amended and restated the promissory note on February 12, 2026 to increase the amount to $450,000 and again amended and restated to promissory note on April 7, 2026 to increase the amount to $550,000. As of April 8, 2026, we had borrowed $507,416.31 under the promissory note. The principal of this note may be drawn down from time to time upon a written request from us to our sponsor. The principal under the note is payable on the date on which we consummate an initial public offering of our securities or the date on which we determine not to conduct an initial public offering of our securities.

Controls and Procedures

We are not currently required to certify the effectiveness of our internal controls as defined by Section 404 of the Sarbanes-Oxley Act. We will be required to comply with the internal control requirements of the Sarbanes-Oxley Act for the fiscal year ending December 31, 2026. Only in the event that we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify as an emerging growth company will we be required to comply with the independent registered public accounting firm attestation requirement on internal control over financial reporting. Further, for as long as we remain an emerging growth company as defined in the JOBS Act, we intend to take advantage of certain exemptions from various reporting requirements, including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirement.

4

As of the date of this Report we have not completed an assessment, nor have our auditors tested our systems, of internal controls. We expect to assess the internal controls of our target business or businesses prior to the completion of our initial business combination and, if necessary, to implement and test additional controls as we may determine are necessary in order to state that we maintain an effective system of internal controls. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy of internal controls. Target businesses we may consider for our initial business combination may have internal controls that need improvement in areas such as:

● staffing for financial, accounting and external reporting areas, including segregation of duties;

● reconciliation of accounts;

● proper recording of expenses and liabilities in the period to which they relate;

● evidence of internal review and approval of accounting transactions;

● documentation of processes, assumptions and conclusions underlying significant estimates; and

● documentation of accounting policies and procedures.

Because it will take time, management involvement and perhaps outside resources to determine what internal control improvements are necessary for us to meet regulatory requirements and market expectations for our operation of a target business, we may incur significant expense in meeting our public reporting responsibilities, particularly in the areas of designing, enhancing, or remediating internal and disclosure controls. Doing so effectively may also take longer than we expect, thus increasing our exposure to financial fraud or erroneous financing reporting.

Once our management’s report on internal controls is complete, we will retain our independent auditors to audit and render an opinion on such report when, or if, required by Section 404. The independent auditors may identify additional issues concerning a target business’s internal controls while performing their audit of internal control over financial reporting.

Off-Balance Sheet Arrangements; Commitments and Contractual Obligations; Quarterly Results

As of the date of this Report, we do not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and do not have any commitments or contractual obligations. No unaudited quarterly operating data is included in this Report as we have conducted no operations to date.

JOBS Act

We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company”, we choose to rely on such exemptions we may not be required to, among other things, (i) provide an independent registered public accounting firm’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of our officers’ compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our potential initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk.

Not required for smaller reporting companies.

Item 8. Financial Statements and Supplementary Data.

This information appears following Item 15 of this Annual Report and is included herein by reference.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure.

5

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of December 31, 2025. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2025, the Company’s disclosure controls and procedures were not effective due to the material weakness described below.

Management identified certain control deficiencies, that when aggregated constitute material weaknesses as follows:

1. Segregation of Duties: Due to operating in a small business environment, we evaluate the cost of implementing controls relative to their potential benefit. As a result, we may not maintain adequate segregation of duties to ensure the proper processing, review, and authorization of all transactions, including non-routine transactions and training activities.

2. Documentation: We do not have sufficient written documentation of our internal control policies and procedures, as required by the Sarbanes-Oxley Act, which applies to the Company for the year ended December 31, 2025.

3. Accounting Resources: Our accounting function lacks sufficient resources, which limits our ability to collect, analyze, and properly review financial information.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

In response to the identified material weaknesses, we have undertaken several initiatives to strengthen our internal controls:

1. Segregation of Duties: We are reevaluating the allocation of responsibilities within our accounting and finance functions to improve segregation of duties, including implementing compensating controls where full segregation is impractical due to our small business environment.

2. Documentation of Controls: We are developing and formalizing written documentation of our internal control policies and procedures, in compliance with the requirements of the Sarbanes-Oxley Act.

3. Accounting Resources: We are augmenting our accounting resources by providing additional training to current personnel and engaging qualified third-party professionals to support the preparation, analysis, and review of financial information, particularly in areas involving complex accounting standards.

These remediation efforts are ongoing and will require time to fully implement and assess for effectiveness. Although we are committed to strengthening our internal controls, we cannot guarantee that these measures will entirely eliminate all material weaknesses or that additional issues will not arise in the future as accounting standards and industry practices continue to evolve.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Management’s Annual Report on Internal Control over Financial Reporting

This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act. We are an emerging growth company, as defined in the JOBS Act, and as such we are exempt from the attestation requirement.

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria set forth in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on this evaluation, management concluded that our internal control over financial reporting was not effective as of December 31, 2025 due to the material weakness described above.

Changes in Internal Control over Financial Reporting

Other than the remediation activities described above, there have been no changes in our internal control over financial reporting during the quarter ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information.

Trading Arrangements

During the quarterly period ended December 31, 2025, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Additional Information

None.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.

6

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors and Executive Officers

As of the date of this Report, our directors and officers are as follows:

Name		Age		Title
Demetrios Mallios		55		Chief Executive Officer and Director
Alan Lewis		50		Chief Financial Officer
Victor (Rock) Klinefelter		51		Chief Operating Officer
Georgios Panou		46		Chief Investment Officer
Alex Saratsis		45		Chief Strategy Officer
Themis Bilionis		48		Chief Business Officer

Mr. Demetrios Mallios has served as our Chief Executive Officer and director since August 2025. Mr. Mallios is the Founder of The Aeon Group, Inc., the parent company of the Aeon Family of Funds and AeonX, as well as other subsidiaries, and has held the position of Chief Executive Officer since July 2013. Mr. Mallios has had a diverse career over the past 30+ years as a fund manager, corporate consultant, investment banker, executive and entrepreneur. Prior to Aeon, his experience as Partner, CEO, COO, and Head of Investment Banking at many firms in the US, China as well as other countries has allowed him to participate as principal investor and/or agent in primary and secondary transactions in private and public companies worldwide. He has served as a director of Invent Ventures, Inc. (OTC: IDEA), a technology venture firm, since November 2017. Mr. Mallios has previous experience also includes Bank of America, UBS, Paulson Investment Company, and Jensyn Acquisition Corp. See “Prior Blank Check Experience.”

Mr. Alan Lewis, has served as our Chief Financial Officer since October 2025. Mr. Lewis has a track record of success as a transformational leader in the financial, investment, and technology industries. He has co-founded and raised funds for multiple ventures, including The Aeon Group, Inc. In his current roles and as an investment banker, Alan has leveraged his extensive background in entrepreneurship, start-ups, mergers & acquisitions, due diligence, strategy, venture capital, corporate finance, private equity, and strategic planning to help companies innovate in the digital arena at firms. He co-founded The Aeon Group, Inc. and since March 2014 has served as Chief Strategy Officer and a director. Since, June 2004, he has been the Managing Member of Aeon X, LLC, a technology platform that offers access to a collection of alternative investments and related products. He received his Bachelor of Arts degree in Political Science from American Public University in 2011 and a Masters of Public Administration in Organizational Leadership from CSU Northridge in 2012. He has also demonstrated the ability to grow private equity and venture capital funds and is dedicated to continuous learning in the rapidly evolving digital landscape, as demonstrated by his pursuit of a doctoral degree in Education and Psychology from Pepperdine University.

Mr. Victor (Rock) Klinefelter, has served as our Chief Operating Officer since October 2025. Mr. Klinefelter brings nearly 30 years of senior management experience across privately held, publicly traded, and Fortune 100 companies such as Leo Burnett, Diesel, and Philip Morris International. He has held national, regional, and global leadership roles in the USA, Asia, and Europe—successfully guiding diverse, multicultural teams through periods of growth and expansion. He began his career at the Leo Burnett Company, where he rose to the role of Global Director. He later served as Global Head of Marketing at Diesel, Regional Marketing Director Asia at Philip Morris International, and Global Commercial Director for Philip Morris International Duty Free. Following these corporate roles, he co-founded a business development venture and currently serves as Chief Operating Officer and Chief of Staff at The Aeon Group. Mr. Klinefelter is a graduate of Amherst College (Massachusetts, USA).

Mr. Georgios Panou has served as our Chief Investment Officer since October 2025. Mr. Panou is a seasoned sports-marketing executive who has co-led Octagon Basketball Europe since 2016, growing it into the continent’s second-largest basketball agency. In May 2022, he founded Upgr8 Sports Management Ltd., building partnerships with Olympic athletes and global brands (VISA, L’Oréal, Allianz, PlayStation) and also co-established Octagon International Soccer, where he orchestrated record-breaking transfers. Since March 2022, Mr. Panou has served as director of OIS Agency Ltd, a soccer focused sports agency. A former national-team coach who led Greece to a World Cup silver in 2006, Georgios holds a degree in Sports Training & Sports Marketing from Visa Skola in Belgrade in 2001.

7

Mr. Alex Saratsis has served as our Chief Strategy Officer since October 2025. Mr. Saratsis is Co-Managing Director of Octagon Basketball, where since 2020 he has co-led a global division representing 40+ NBA stars and overseeing over $2 billion in active contracts and endorsements. With two decades of international sports-management experience, Alex built Octagon’s basketball operations across North America, Europe, Asia, and South America—recruiting elite talent, negotiating landmark deals (including Giannis Antetokounmpo’s record extensions), and launching Octagon54 to develop African basketball prospects. A Northwestern graduate with a Bachelor’s Degree in Political Scient in May 2002, fluent in four languages, Alex also teaches Sports Administration at his alma mater.

Mr. Themis Bilionis has served as our Chief Business Officer since October 2025. Mr. Bilionis, born in Athens in 1977, has extensive operational expertise in European sports management. After starting his career at Basketopolis S.A. as Head of Marketing and Communications, he co-founded the Octagon Basketball Europe network in 2013, later merging to form OBE SPORTS MANAGEMENT LTD in 2020. Since March 2021, Mr. Bilionis has served as Director of Operations of OBE Sports Management LTD, as well as a member of the Board of Directors. Mr. Bilionis received his Bachelor of Arts degree from Panteion University of Social Sciences in 1996 and a Master of Arts degree from University of Durham Business School in 2003.

Family Relationships

No family relationships exist between any of our directors or executive officers.

Involvement in Certain Legal Proceedings

There are no material proceedings to which any director or executive officer has been involved in the last ten years that are material to an evaluation of the ability or integrity of any director or officer.

Number and Terms of Office of Officers and Directors

Our board of directors consists of one member.

Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate.

ITEM 11. EXECUTIVE COMPENSATION

Executive Officers and Director Compensation

Our officers and sole director have not received compensation for services rendered to us.

Compensation Committee Interlocks and Insider Participation

None of our officers currently serves, or in the past year has served, as a member of the compensation committee of any entity that has one or more officers serving on our Board of Directors.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information, as of April 14, 2026, with respect to the beneficial ownership of our voting securities by (i) each person who is known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares, (ii) each of our officers and directors, and (iii) all of our officers and directors as a group.

	Number of
	Shares		Percentage of
	Beneficially		Outstanding
Name and Address of Beneficial Owner	Owned		Shares
Aeon Acquisition Partners I LLC(1)		12,321,429		100	%

(1) Aeon Acquisition Partners I LLC (“Sponsor”) is the sponsor and majority shareholder of Aeon. Messrs. Demetrios Mallios, our Chief Executive Officer, and Alan Lewis, our Chief Financial Officer, are the managing members of Aeon Acquisition Partners I LLC, our sponsor. As such, they may be deemed to have or share beneficial ownership of the Class B ordinary shares held directly by Aeon Acquisition Partners I LLC. Such persons disclaim any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. The business address of each Aeon, Mr. Mallios and Mr. Lewis is at 66 West Flagler Street, Suite 900, Miami, FL 33130.

8

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

On August 20, 2025, our Sponsor and certain directors and officers, either directly or indirectly, purchased an aggregate of 12,321,429 Class B ordinary shares for an aggregate purchase price of $25,000, or approximately $0.002 per share.

On August 20, 2025, we issued an unsecured promissory note to our sponsor with an aggregate principal amount of up to $200,000, which is non-interest-bearing. We amended and restated such note as of December 30, 2025 to increase the amount to $350,000 and further amended and restated the promissory note on February 12, 2026 to increase the amount to $450,000 and again amended and restated to promissory note on April 7, 2026 to increase the amount to $550,000. As of April 8, 2026, we had borrowed $507,416.31 under the promissory note. The principal of this note may be drawn down from time to time upon a written request from us to our sponsor. The principal under the note is payable on the date on which we consummate an initial public offering of our securities or the date on which we determine not to conduct an initial public offering of our securities.

ITEM 14. Principal Accountant Fees and Services.

The firm of RBSM LLP (“RBSM”), acts as our independent registered public accounting firm. The following is a summary of fees paid to RBSM for services rendered.

Audit Fees. Audit fees consist of the aggregate fees for professional services rendered for the audit of our year-end financial statements and services that are normally provided by RBSM in connection with regulatory filings. The aggregate fees of RBSM for professional services rendered for the (i) audit of our initial registration, (ii) audit of our annual financial statements, and (iii)review of the financial information included in our Form 10-K for the period from August 1, 2025 (inception) through December 31, 2025, totaled approximately $70,000. The above amounts include interim procedures and audit fees.

Audit-Related Fees. During the period from August 1, 2025 (inception) through December 31, 2025, our independent registered public accounting firm rendered assurance and related services related to the performance of the audit or review of financial statements, which totaled $15,000.

Tax Fees. During the period from August 1, 2025 (inception) through December 31, 2025, our independent registered public accounting firm did not render services to us for tax compliance, tax advice and tax planning.

All Other Fees. During the period from August 1, 2025 (inception) through December 31, 2025, there were no fees billed for products and services provided by our independent registered public accounting firm other than those set forth above

9

PART IV

ITEM 15. Exhibits, Financial Statement Schedules

Item 15. Exhibit and Financial Statement Schedules.

(a) The following documents are filed as part of this Report:

(1) Financial Statements

Report of Independent Registered Public Accounting Firm (PCAOB ID: 587)	F-2
Balance Sheet as of December 31, 2025	F-3
Statement of Operations for the period from August 1, 2025 (inception) through December 31, 2025	F-4
Statement of Changes in Shareholder’s Deficit for the period from August 1, 2025 (inception) through December 31, 2025	F-5
Statement of Cash Flows for the period from August 1, 2025 (inception) through December 31, 2025	F-6
Notes to the Financial Statements	F-7 – F-17

(2) Financial Statement Schedules

All financial statement schedules are omitted because they are not applicable or the amounts are immaterial and not required, or the required information is presented in the financial statements and notes thereto beginning on page F-1 of this Report.

(3) Exhibits

We hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits that are incorporated herein by reference can be inspected on the SEC website at www.sec.gov.

Item 16. Form 10-K Summary.

Not applicable.

10

(3) Exhibits

We hereby file as part of this Report the exhibits listed in the attached Exhibit Index.

Exhibit No.	Description
3.1	Memorandum and Articles of Association
4.1	Specimen Ordinary Shares Certificate
10.1	Securities Subscription Agreement, between the Registrant and the Sponsor.
10.2	Promissory Note Dated August 26, 2025, issued to the Sponsor
10.3	Amended and Restated Promissory Note, dated December 30, 2025, issued to the Sponsor
10.4	Second Amended and Restated Promissory Note, dated February 12, 2026 issued to the Sponsor
10.5	Third Amended and restated Promissory Note, dated April 7, 2026 issued to the Sponsor
10.6	Indemnification Agreement dated January 29, 2026
10.7	Settlement Agreement  dated March 26, 2026, by and among the Registrant, Chardan Capital Markets, LLC, Demetrios Mallios, The Aeon Group, Inc., and D. Boral Capital, LLC
21.1	List of Subsidiaries.
31.1	Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*	Inline XBRL Taxonomy Extension Schema Document.
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*	Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

*

Filed herewith.

**

Furnished herewith. This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filings of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

ITEM 16. FORM 10-K SUMMARY

Not applicable.

11

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

April 14, 2026	AEON ACQUISITION I CORP.
	By:	/s/ Demetrios Mallios
	Name:	Demetrios Mallios
	Title:	Chief Executive Officer (Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Name	Position	Date
/s/ Demetrios Mallios	Chief Executive Officer	April 14, 2026
Demetrios Mallios	(Principal Executive Officer)
/s/ Alan Lewis	Chief Financial Officer	April 14, 2026
Alan Lewis	(Principal Financial and Accounting Officer)

12

INDEX TO FINANCIAL STATEMENTS

	Page(s)
Report of Independent Registered Public Accounting Firm (PCAOB ID: 587)	F-2
Balance Sheet as of December 31, 2025	F-3
Statement of Operations for the period from August 1, 2025 (inception) through December 31, 2025	F-4
Statement of Changes in Shareholder’s Deficit for the period from August 1, 2025 (inception) through December 31, 2025	F-5
Statement of Cash Flows for the period from August 1, 2025 (inception) through December 31, 2025	F-6
Notes to the Financial Statements	F-7 – F-17

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

New York Office:   805 Third Avenue New York, NY 10022 212.838-5100   www.rbsmllp.com

To the Stockholder and Board of Directors of

Aeon Acquisition I Corp.

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Aeon Acquisition I Corp. (the “Company”) as of December 31, 2025, and the related statement of operations, changes in shareholder’s deficit, and cash flows for the period from August 1, 2025 (inception) through December 31, 2025, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the period from August 1, 2025 (inception) through December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

Explanatory Paragraph — Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 2, the Company’s ability to execute its business plan is dependent upon its completion of the proposed initial public offering described in Note 1 to the financial statements. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Notes 2. The financial statements do not include any adjustments that become necessary should the Company be unable to continue as a going concern.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we were required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ RBSM LLP

We have served as the Company’s auditor since 2025.

New York, NY

April 9, 2026,

except Note 9

dated April 14, 2026

New York, NY Washington DC Mumbai and Pune, India San Francisco, CA

Houston, TX Boca Raton, FL Las Vegas, NV Beijing, China Athens, Greece

Member: ANTEA International with affiliated offices worldwide

F-2

AEON ACQUISITION I CORP.

BALANCE SHEET

	December 31, 2025
ASSETS
Deferred offering costs	$	299,009
Total Assets		299,009
LIABILITIES AND SHAREHOLDER’S DEFICIT
Current Liabilities
Accrued offering costs	$	35,000
Promissory note – related party		307,760
Total Current Liabilities		342,760
Commitments and Contingencies		-
Shareholder’s Deficit
Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding		-
Class A ordinary shares, $0.0001 par value; 450,000,000 shares authorized; none issued and outstanding		-
Class B ordinary Shares, $0.0001 par value; 45,000,000 shares authorized; 12,321,429 issued and outstanding(1)		1,232
Additional paid-in capital		23,768
Accumulated deficit		(43,751	)
Subscription receivable		(25,000	)
Total Shareholder’s Deficit		(43,751	)
Total Liabilities and Shareholder’s Deficit	$	299,009

(1) Includes an aggregate of 1,607,143 Class B ordinary Shares which will be surrendered to us for no consideration to the extent that the underwriters’ over-allotment is not exercised in full or in part.

The accompanying notes are an integral part of these financial statements.

F-3

AEON ACQUISITION I CORP.

STATEMENT OF OPERATIONS

	For the Period from August 1, 2025 (inception) through
	December 31, 2025
Formation and operating costs	$	(8,751	)
Professional fees		(35,000	)
Net Loss	$	(43,751	)
Weighted average shares outstanding, basic and diluted (1)		10,714,286
Basic and diluted net loss per ordinary share	$	(0.00	)

(1) Excludes an aggregate of 1,607,143 Ordinary Shares which will be surrendered to us for no consideration to the extent that the underwriters’ over-allotment is not exercised in full or in part.

The accompanying notes are an integral part of these financial statements.

F-4

AEON ACQUISITION I CORP.

STATEMENT OF CHANGES SHAREHOLDER’S DEFICIT

FOR THE PERIOD FROM AUGUST 1, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025

	Class B Ordinary				Additional Paid-In		Accumulated			Subscription			Total Shareholder’s
	Shares		Amount		Capital		Deficit			Receivable			Deficit
Balance – August 1, 2025 (inception)		-	$	-	$	-	$	-		$	-		$	-
Class B ordinary shares issued to Sponsor(1)		12,321,429		1,232		23,768		-			(25,000	)		-
Net loss		-		-		-		(43,751	)		-			(43,751	)
Balance – December 31, 2025		12,321,429	$	1,232	$	23,768	$	(43,751	)	$	(25,000	)	$	(43,751	)

(1) Includes an aggregate of 1,607,143 Ordinary Shares which will be surrendered to us for no consideration to the extent that the underwriters’ over-allotment is not exercised in full or in part.

The accompanying notes are an integral part of these financial statements.

F-5

AEON ACQUISITION I CORP.

STATEMENT OF CASH FLOWS

	For the Period from August 1, 2025 (inception) through December 31, 2025
Cash flows from Operating Activities:
Net Loss	$	(43,751	)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation and operating costs paid by Sponsor under Promissory Note – Related Party		43,751
Accrued offering costs		-
Net cash provided by operating activities		-
Cash flows from Financing Activities:
Proceeds from issuance of ordinary shares to Sponsor		-
Payment of offering costs		-
Net cash provided by financing activities		-
Net Change in Cash		-
Cash – Beginning of period		-
Cash – End of period	$	-
Supplemental Disclosures of Noncash Financing Activities
Deferred offering costs included in promissory note	$	264,009
Deferred offering costs included in accrued offering costs	$	35,000
Founder shares issued for subscription fee receivable	$	25,000

The accompanying notes are an integral part of these financial statements.

F-6

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

AEON ACQUISITION I CORP. (the “Company”) is a blank check company incorporated in the Cayman Islands as an exempted company on August 1, 2025. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, the Company intends to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business.

On December 31, 2025, the Company had not yet commenced any operations. All activity through December 31, 2025 related to the Company’s formation and the Proposed Offering (as defined below). The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Proposed Offering. The Company has selected December 31 as its fiscal year end. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through a proposed initial public offering of 25,000,000 units at $10.00 per unit (or 28,750,000 units if the underwriters’ over-allotment option is exercised in full) (the “Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”) which is discussed in Note 3 (the “Proposed Offering”) and the sale of 300,000 Private Placement Units (whether or not the over-allotment option is exercised) (the “Private Placement Units”) at a price of $10.00 per Unit in a private placement to the Company’s sponsor, AEON ACQUISITION PARTNERS I, LLC (the “Sponsor”), that will close simultaneously with the Proposed Offering. The sponsor will subscribe to purchase (a) 300,000 private placement units and (b) 675,000 Class A ordinary shares, par value $0.0001 per share, of our company, which shares shall be subject to certain restrictions until the consummation of the initial business combination (each, a “restricted Class A share”) for an aggregate purchase price of $3,000,000 (whether or not the underwriters’ over-allotment option is exercised in full) in a private placement (referred to herein as the “Private Placement,” and the private placement units and restricted Class A shares together, the “private placement securities”). The Company intends to list the Units on the Nasdaq Global Market (“Nasdaq”). The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Proposed Offering and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (excluding taxes payable on the income earned on the trust account) at the time of the signing of an agreement to enter into a Business Combination.

The Company will complete a Business Combination only if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Offering, management has agreed that $10.00 per Unit sold in the Proposed Offering, including the proceeds of the sale of the Private Placement Units, will be held in a trust account (“Trust Account”) and may be invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, that invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended business combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company hold investments in the trust account, the Company may, at any time (based on our management team’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand deposit account at a bank.

The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of how they vote for the Business Combination.

F-7

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). These ordinary shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.

The sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with the completion of our initial business combination; (ii) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association; (iii) waive their rights to liquidating distributions from the trust account with respect to their founder shares and private shares if the Company fail to complete our initial business combination within the completion window, although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if the Company fail to complete our initial business combination within the prescribed time frame and to liquidating distributions from assets outside the trust account; and (iv) vote any founder shares and private shares held by them and any public shares purchased during or after this offering (including in open market and privately-negotiated transactions) in favor of our initial business combination (except that any public shares such parties may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act would not be voted in favor of approving the business combination transaction).

The Company will have until 15 months from the closing of the Proposed Offering, with two (2) three-month extension at the option of the sponsor (as may be extended by shareholder approval to amend our amended and restated memorandum and articles of association to extend the date by which the Company must consummate our initial business combination) or until such earlier liquidation date as our board of directors may approve, to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

F-8

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

The Sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us (except for the Company’s independent auditors), or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per public share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked our sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and the Company believe that our sponsor’s only assets are securities of our company. Therefore, the Company cannot assure you that our sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the trust account, the funds available for our initial business combination and redemptions could be reduced to less than $10.00 per public share. In such event, the Company may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption of your public shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanying financial statements are presented in U.S. Dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC.

Going Concern Consideration

The Company’s financial statements are prepared assuming it will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As of December 31, 2025, the Company has a working capital deficit of $342,760, and no cash, raising substantial doubt about its ability to continue for a period of time within one year after the date that the financial statements are issued.

Per ASC 205-40. Management’s plans include access to up to $1,500,000 in working capital loans from the Sponsor (subsequent to December 31, 2025), convertible into Class A shares at $10.00 post-business combination, which management believes will be sufficient to consummate its initial public offering and proceed with its plans to find a target acquisition over the next 12 months. However, there are no assurances that the Company will be able to raise capital on terms acceptable to the Company, or at all. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company expects to continue to incur significant costs in pursuit of its financing and acquisition plans.

Liquidity and Capital Resources

As of December 31, the Company had $0 cash and cash equivalents and a working capital deficit of $342,760 ($35,000 accrued offering costs and $307,760 related-party note as of December 31, 2025), with $299,009 in deferred offering costs. Capital includes 12,321,429 Class B shares issued to the Sponsor for a $25,000 uncollected subscription. Management relies on the proposed offering proceeds and a potential $1,500,000 Sponsor loan (Note 5) to fund operations and a business combination, though completion is uncertain.

Emerging growth company

The Company is an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act of 1933, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), as such the Company is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include, but are not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.

F-9

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash or cash equivalents as of December 31, 2025.

Deferred offering costs

The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are related to the Proposed Offering. Financial Accounting Standards Board (“FASB”) ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Proposed Offering proceeds from the Public Units between Class A ordinary shares, rights and warrants, using the residual method by allocating Proposed Offering proceeds first to assigned value of the rights, then warrants and the last to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares subject to possible redemption will be charged to temporary equity, and offering costs allocated to the rights and warrants included in the Public Units and Private Placement Units will be charged to shareholder’s equity as the warrants, after management’s evaluation, will be accounted for under equity treatment. Should the Proposed Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations. As of December 31, 2025, the Company incurred offering costs of $299,009, of which $264,009 have been paid and $35,000 are included in “Accrued offering costs” on the accompanying balance sheet.

Income taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of December 31, 2025 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

F-10

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

The Company is considered to be a Cayman business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the provision for income taxes was deemed to be de minimis for the period from August 1, 2025 (inception) to December 31, 2025.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed to the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the Proposed Offering.

Warrant

The Company will account for the Public and Private Warrants to be issued in connection with the Proposed Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Accordingly, the Company evaluated and will classify the warrant instruments under equity treatment at their assigned values. There are no Public or Private Warrants currently outstanding as of December 31, 2025.

Share Rights

The Company accounts for the Public Rights (defined below) issued in connection with the Proposed Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the rights under equity treatment at their assigned value.

Net loss per ordinary share

The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. At December 31, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented.

Concentration of credit risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair value of financial instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

F-11

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

Risks and Uncertainties

The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the escalation of the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.

Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

NOTE 3. PROPOSED OFFERING

Pursuant to the Proposed Offering, the Company intends to issue Units, each consisting of one ordinary share, one redeemable warrant (“Public Warrant”), and one right (“Public Right”). Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share upon consummation of an initial Business Combination. No fractional shares will be issued upon conversion of the rights.

NOTE 4. PRIVATE PLACEMENT

The Sponsor has committed to purchase Private Placement Units in a private placement that will occur simultaneously with the closing of the Proposed Offering. The proceeds from the sale of the Private Placement Units will be added to the net proceeds from the Proposed Offering held in the Trust Account. The Private Placement Units are identical to the units sold in the Proposed Offering, as described in Note 7. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to applicable law), and the Private Warrants will expire worthless.

F-12

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

NOTE 5. RELATED PARTY TRANSACTIONS

Founder shares

On August 20, 2025, the Company issued an aggregate of 12,321,429 founder shares to the Sponsor for an aggregate purchase price of $25,000 in cash. The funds were not received by December 31, 2025. Such ordinary shares includes an aggregate of up to 1,607,143 shares which will be surrendered to us to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own 30% of the outstanding shares after this offering (not including the Class A ordinary shares that are included within the private units).

The founder shares are designated as Class B ordinary shares and, except as described below, are identical to the Class A ordinary shares included in the units being sold in this offering, and holders of founder shares have the same shareholder rights as public shareholders, except that (i) the founder shares are subject to certain transfer restrictions, as described in more detail below, (ii) our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to (A) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with the completion of our initial business combination, (B) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (a) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination within the completion window or (b) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity, (C) waive their rights to liquidating distributions from the trust account with respect to their founder shares and private shares if we fail to complete our initial business combination within the completion window, although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within such time period and to liquidating distributions from assets outside the trust account and (D) vote any founder shares held by them and any public shares purchased during or after this offering (including in open market and privately-negotiated transactions) in favor of our initial business combination (except that any public shares such parties may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act would not be voted in favor of approving the business combination transaction), (iv) the founder shares are automatically convertible into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment as described herein and in our amended and restated memorandum and articles of association, and (v) prior to the closing of our initial business combination, only holders of our Class B ordinary shares will be entitled to vote on the appointment and removal of directors or continuing the company in a jurisdiction outside the Cayman Islands (including any ordinary resolution required to amend our constitutional documents or to adopt new constitutional documents, in each case, as a result of our approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands).

With certain limited exceptions, the founder shares are not transferable, assignable or saleable (except to our officers and directors and other persons or entities affiliated with our sponsor, each of whom will be subject to the same transfer restrictions) until the completion of our initial business combination.

Promissory Note — Related Party

On August 20, 2025, the Sponsor issued an unsecured promissory note to the Company, pursuant to which the Company may borrow up to an aggregate principal amount of $200,000, to be used for payment of costs related to the Proposed Offering. On December 30, 2025, the Company restated and amended the note to increase the aggregate principal amount to $350,000. On February 12, 2026, the Company further restated and amended the note to increase the aggregate principal amount to $450,000 and again on April 7, 2026 to increase the aggregate principal amount to $550,000. The note is non-interest bearing and the Company intends to cancel the promissory note in exchange for 55,000 private placement units and 123,750 restricted Class A ordinary shares in connection with the closing of this offering. As of April 8, 2026, the Company has borrowed $507,461.31 under the promissory note with our Sponsor.

Administrative Services Arrangement

An affiliate of our Sponsor has agreed, commencing from the date that the Company’s securities are first listed on Nasdaq, through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company our Sponsor certain office space, utilities and secretarial and administrative support as may be reasonably required by the Company. The Company has agreed to pay Aeon Group I.K.E., the affiliate of our Sponsor, $20,000 per month, for up to 15 months, subject to extension to up to 21 months, as provided in the Company’s registration statement, for such administrative services.

F-13

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Up to $1,500,000 in working capital loans may be convertible into Class A ordinary shares of the post-combination entity at $10.00 per share; following the offering, the board may approve working capital loans that may be convertible into units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2025, no amounts under such loans have been drawn.

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the (i) founder shares, which were issued in a private placement prior to the closing of this offering, (ii) Private Placement Units (including the component securities as well as any securities underlying those component securities), which will be issued in a private placement simultaneously with the closing of the Proposed Offering and (iii) private units (including the component securities as well as any securities underlying those component securities) that may be issued upon conversion of working capital loans will have registration rights to require the Company to register a sale of any of our securities held by them and any other securities of the company acquired by them prior to the consummation of a Business Combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the Business Combination. The registration rights granted are limited to three demands at the Company’s expense and unlimited “piggy-back” rights for periods of five and seven years, respectively, from the commencement of sales of the Proposed Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company will grant the underwriters a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments at the Proposed Offering price, less the underwriting discounts and commissions.

The underwriters will be entitled to a cash underwriting discount of $1,000,000 of the gross proceeds of the Proposed Offering (whether or not the over-allotment option is exercised). In addition, the underwriters are entitled to a deferred fee of three percent (3.0%) of the gross proceeds of the Proposed Offering, or $7,500,000 (or up to $8,625,000 if the underwriters’ over-allotment is exercised in full). The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

Settlement of Legal Proceeding

We entered into a Settlement Agreement with respect to an arbitration that was filed against the Company, Demetrios Mallios, The Aeon Group, Inc. (“AGI”), and Geneships Acquisition Corp. with the American Arbitration Association in February 2026 (AAA Case No. 01-26-0000-6229) by Chardan Capital Markets, LLC (“Chardan”) in connection with fees for certain capital-raising activities, including related to a possible SPAC transaction, under a 2023 engagement letter and 2024 amendment that preceded our formation. The total amount sought was not less than $15,000,000.

In February 2026, we commenced a special proceeding in the Supreme Court of the State of New York (Index No. 65082/2026) seeking to permanently stay the arbitration as against the Company. Demetrios Mallios, our Chairman and Chief Executive Officer, and, his affiliate, The Aeon Group, Inc., jointly and severally indemnified the Company and its shareholders for any liabilities, losses, or expenses arising from the arbitration and any related claims.

On March 20, 2026, the parties agreed to a binding settlement term sheet and on March 26, 2026, the Company entered into a Settlement Agreement (the “Settlement Agreement”) with Chardan, Mr. Mallios, Geneships Acquisition Corp., AGI and D. Boral Capital LLC (“D. Boral”).

The Settlement Agreement is contingent upon the closing of this offering and will become effective only upon the closing of this offering (the “Effective Time”). The Settlement Agreement provides, among other things, that Chardan will serve as lead book-running manager and D. Boral will serve as co-lead book-running manager for this offering and that underwriting compensation in connection with this offering will be allocated between them. The Settlement Agreement further provides that, following the Effective Time, the arbitration and related court proceeding will be dismissed with prejudice, and mutual general releases between us, Demetrios Mallios, Geneships Acquisition Corp., and AGI that are contained in the Settlement Agreement will become effective pursuant to which each party, on behalf of itself and its affiliates and related parties, will release the other parties and their respective affiliates and representatives from all claims, whether known or unknown, arising out of or relating to events occurring on or prior to March 25, 2026 other than obligations arising under the Settlement Agreement and related transaction documents. There is no other separate consideration paid to or for any party.

If this offering does not close on or prior to May 25, 2026, unless extended by mutual agreement of the Company, Chardan and D. Boral, the Settlement Agreement will automatically terminate and be of no further force or effect. In such event, the arbitration and related proceedings could continue, and the Company and its affiliates could remain subject to claims in excess of $15,000,000. If the Settlement Agreement does not become effective, the arbitration and related court proceedings would resume, and the Company’s ability to complete this offering or any subsequent initial business combination could be materially and adversely affected.

The Settlement Agreement does not affect the funds held in the trust account established in connection with this offering. Other than the deferred underwriting commissions which are payable from the trust account upon the completion of an initial business combination, no amounts payable under or in connection with the Settlement Agreement will be paid from the trust account. The Company does not expect that any liabilities arising under or in connection with the Settlement Agreement, including any claim for breach thereof, would be payable from the trust account, and the Settlement Agreement provides that neither the Company nor the trust account will be responsible for any payments required to effect the allocation of underwriting compensation between the underwriters. No additional compensation is payable by the Company in connection with the Settlement Agreement other than the underwriting compensation.

  

F-14

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

NOTE 7. SHAREHOLDER’S DEFICIT

Preference shares — The Company is authorized to issue 5,000,000 ordinary shares with a par value of $0.0001 per share. Holders of the Company’s ordinary shares are entitled to one vote for each share. On December 31, 2025, there were no preferred shares issued or outstanding.

Class A Ordinary shares — The Company is authorized to issue 450,000,000 ordinary shares with a par value of $0.0001 per share. Holders of the Company’s ordinary shares are entitled to one vote for each share. On December 31, 2025, there were no class A ordinary shares issued or outstanding.

Class B Ordinary shares — The Company is authorized to issue 45,000,000 ordinary shares with a par value of $0.0001 per share. Holders of the Company’s ordinary shares are entitled to one vote for each share. On August 20, 2025, the Company issued an aggregate of 12,321,429 ordinary shares to the Sponsor for an aggregate purchase price of $25,000 in cash, of which 1,607,143 shares held by the Sponsor are subject to forfeiture to the extent that the underwriter’s over-allotment option is not exercised in full. On December 31, 2025, there were 12,321,429 ordinary shares issued and outstanding.

The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination, or at any time prior thereto at the option of the holder thereof, on a one-for-one basis, subject to adjustment as provided herein. Because our sponsor acquired the Class B ordinary shares at a nominal price, our public shareholders will incur an immediate and substantial dilution upon the closing of this offering, assuming no value is ascribed to the warrants included in the units. In the case that additional Class A ordinary shares, or equity-linked securities (as described herein), are issued or deemed issued in excess of the amounts issued in this offering and related to the closing of our initial business combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 30% of the sum of (i) the total number of all Class A ordinary shares outstanding upon the completion of this offering (including any Class A ordinary shares issued pursuant to the underwriters’ over-allotment option and excluding the Class A ordinary shares that are included within the private units), plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial business combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any units issued to our sponsor or any of its affiliates or to our officers or directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial business combination; provided that such conversion of founder shares will never occur on a less than one-for-one basis.

Holders of record of the Company’s Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company is generally required to approve any matter voted on by the Company’s shareholders. Approval of certain actions require an ordinary resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of in excess of 50 percent of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the Company’s amended and restated memorandum and articles of association, such actions include amending the amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following the Company’s initial Business Combination, the holders of more than 50% of the ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class B ordinary shares will (i) have the right to vote on the appointment and removal of directors and (ii) be entitled to vote on continuing the Company in a jurisdiction outside the Cayman Islands (including any ordinary resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the Class A ordinary shares will not be entitled to vote on these matters during such time. These provisions of our amended and restated memorandum and articles of association may only be amended if approved by an ordinary resolution passed by the affirmative vote of the holders representing at least 90% of the issued Class B ordinary shares.

F-15

AEON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS

Warrants — Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants will become exercisable 30 days after the completion of our initial business combination, provided that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or we permit holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if our Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement. The Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.

The Company may call the Warrants for redemption:

● in whole and not in part;

● at a price of $0.01 per warrant; upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and

● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day period commencing at least 30 days after completion of our initial business combination and ending three business days before we send the notice of redemption to the warrant holders.

The private warrants will be identical to the warrants sold in this offering except that, so long as they are held by our sponsor or its permitted transferees, the private warrants (i) are locked-up until the completion of our initial business combination and (ii) will be entitled to registration rights.

The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

The exercise price is $11.50 per share, subject to adjustment as described herein. In addition, if (x) we issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our initial shareholders or their affiliates, without taking into account any founder shares held by our initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds (including from such issuances and this offering), and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial business combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-fifth (1/5) of one ordinary share upon consummation of the initial Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the initial business combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-fifth (1/5) of one ordinary share underlying each right upon consummation of the Business Combination. If the Company is unable to complete the initial Business Combination within the required time period and the Company will redeem the public shares for the funds held in the Trust Account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.

F-16

AEON ACQUISITION I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

NOTE 8. SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

The Company’s chief operating decision maker has been identified as the Chief Financial Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

	For the Period from August 1, 2025 (inception) through December 31, 2025
Formation and operating costs	$	(43,751	)

The key measures of segment profit or loss reviewed by the CODM are formation and operating costs. Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Proposed Offering and eventually a Business Combination within the Combination Period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.

NOTE 9. SUBSEQUENT EVENTS

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions through April 14, 2026, which was the date these financial statements were available for issuance. Based upon this review, the Company has identified below subsequent events that would have required adjustment or disclosure in the financial statements.

On February 12, 2026, the Company further restated and amended the note to increase the aggregate principal amount to $450,000.

On April 7, 2026, the Company further restated and amended the note to increase the aggregate principal amount to $550,000.

F-17

EX-3.1

Exhibit 3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-4.1

Exhibit 4.1

NUMBER

C-

SHARES

SEE REVERSE FOR CERTAIN DEFINITIONS

CUSIP [_]

AEON ACQUISITION I CORP.

INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS

CLASS A ORDINARY SHARES

This Certifies that ________________________________ is the owner of ________________________________ FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF U.S.$0.0001 EACH OF

AEON ACQUISITION I CORP.

(THE “COMPANY”)

subject to the Company’s amended and restated memorandum and articles of association and transferable on the register of members of the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed.

The Company will be forced to redeem all of its Class A Ordinary Shares if it is unable to complete a business combination within the time period set forth in the Company’s amended and restated memorandum and articles of association, as the same may be amended from time to time, or such by later date approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association, all as more fully described in the Company’s final prospectus dated [            ], 2026.

This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar of the Company.

Witness the facsimile signature of a duly authorized signatory of the Company.

Authorized Signatory	Transfer Agent
[Name:]	[Name:]
	[Title:]

AEON ACQUISITION I CORP.

The Company will furnish without charge to each shareholder who so requests, a statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of shares or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights. This certificate and the shares represented thereby are issued and shall be held subject to all the provisions of the amended and restated memorandum and articles of association of the Company and all amendments thereto and resolutions of the Board of Directors providing for the issue of securities (copies of which may be obtained from the secretary of the Company), to all of which the holder of this certificate by acceptance hereof assents.

The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:

TEN COM	-	as tenants in common	UNIF GIFT MIN ACT	-		Custodian
					(Cust)		(Minor)
TEN ENT	-	as tenants by the entireties
JT TEN	-	as joint tenants with right of survivorship and not as tenants in common			under Uniform Gifts to Minors Act
					(State)

Additional abbreviations may also be used though not in the above list.

For value received, __________________ hereby sells, assigns and transfers unto __________________

(PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER(S) OF ASSIGNEE(S))

(PLEASE PRINT OR TYPEWRITE NAME(S) AND ADDRESS(ES), INCLUDING ZIP CODE, OF ASSIGNEE(S))

Class A Ordinary Shares represented by the within Certificate, and does hereby irrevocably constitute and appoint ____________ Attorney to transfer the said Class A Ordinary Shares on the register of members of the within named Company with full power of substitution in the premises.

Dated: __________
	Notice:	The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without alteration or enlargement or any change whatever.
Signature(s) Guaranteed:
THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (OR ANY SUCCESSOR RULE)).

In each case, as more fully described in, and subject to the terms and conditions described in, the Company’s final prospectus for its initial public offering dated , 2026, the holder(s) of this certificate shall be entitled to receive a pro rata portion of certain funds held in the trust account established in connection with the Company’s initial public offering only in the event that (i) the Company redeems the Class A Ordinary Shares sold in its initial public offering and liquidates because it does not consummate an initial business combination within the time period set forth in the Company’s amended and restated memorandum and articles of association, as the same may be amended from time to time, or by such later date approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association, (ii) the Company redeems the Class A Ordinary Shares sold in its initial public offering in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial business combination or to redeem 100% of the Class A Ordinary Shares if it does not complete its initial business combination within the time period set forth in the Company’s amended and restated memorandum and articles of association, as the same may be amended from time to time, or by such later date approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association, or (B) with respect to any other provision relating to the holder(s)’(s) rights or pre-initial business combination activity, or (iii) if the holder(s) seek(s) to redeem for cash his, her, its or their respective Class A Ordinary Shares represented by this certificate in connection with a tender offer (or proxy solicitation, solely in the event the Company seeks shareholder approval of the proposed initial business combination) setting forth the details of a proposed initial business combination. In no other circumstances shall the holder(s) have any right or interest of any kind to or in the trust account.

EX-10.1

Exhibit 10.1

Aeon Acquisition I Corp.

66 WEST FLAGLER STREET, SUITE 900

MIAMI, FL 33130

August 20, 2025

Aeon Acquisition Partners I LLC

66 West Flagler Street, Suite 900

Miami, FL 33130

RE: Securities Subscription Agreement

Ladies and Gentlemen:

This agreement (the “Agreement”) is between Aeon Acquisition Partners I LLC, a Delaware limited liability company (the “Subscriber” or “you”), and Aeon Acquisition I Corp., a Cayman Islands exempted company (the “Company,” “we” or “us”). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to subscribe for and purchase 12,321,429 Class B ordinary shares, $0.0001 par value per share of the Company (the “Shares”), up to 1,607,143 of which are subject to surrender and cancellation by you if the underwriters of the initial public offering (“IPO”) of units (“Units”) of the Company, do not fully exercise their over-allotment option (the “Over-allotment Option”). The Company and the Subscriber’s agreements regarding such Shares are as follows:

1. Purchase of Securities.

1.1. Subscription and Purchase of Shares. For the sum of $25,000 (the “Purchase Price”), which the Company acknowledges receiving in cash, the Company hereby issues the Shares to the Subscriber, and the Subscriber hereby subscribes for and purchases the Shares from the Company, 1,607,143 of which are subject to surrender and cancellation, on the terms and subject to the conditions set forth in this Agreement. Concurrently with the Subscriber’s execution of this Agreement, the Company shall effect such issuance in the register of members of the Company. The Subscriber hereby surrenders to the Company for no consideration the one Class B ordinary share, $0.0001 par value that the Subscriber holds in the Company.

2. Representations, Warranties and Agreements.

2.1. Subscriber’s Representations, Warranties and Agreements. To induce the Company to issue the Shares to the Subscriber, the Subscriber hereby represents and warrants to the Company and agrees with the Company as follows:

2.1.1. No Government Recommendation or Approval. The Subscriber understands that no federal or state agency has passed upon or made any recommendation or endorsement of the offering of the Shares.

2.1.2. No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Subscriber of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the formation and governing documents of the Subscriber, (ii) any agreement, indenture or instrument to which the Subscriber is a party or (iii) any law, statute, rule or regulation to which the Subscriber is subject, or any agreement, order, judgment or decree to which the Subscriber is subject.

2.1.3. Organization and Authority. The Subscriber is a Cayman Islands limited company, validly existing and in good standing under the laws of the Cayman Islands and possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement. Upon execution and delivery by you, this Agreement is a legal, valid and binding agreement of Subscriber, enforceable against Subscriber in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting the enforcement of creditors’ rights generally and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity).

2.1.4. Experience, Financial Capability and Suitability. Subscriber is: (i) sophisticated in financial matters and is able to evaluate the risks and benefits of the investment in the Shares and (ii) able to bear the economic risk of its investment in the Shares for an indefinite period of time because the Shares have not been registered under the Securities Act (as defined below) and therefore cannot be sold unless subsequently registered under the Securities Act or an exemption from such registration is available. Subscriber is capable of evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests. Subscriber must bear the economic risk of this investment until the Shares are sold pursuant to: (i) an effective registration statement under the Securities Act or (ii) an exemption from registration available with respect to such sale. Subscriber is able to bear the economic risks of an investment in the Shares and to afford a complete loss of Subscriber’s investment in the Shares.

2.1.5. Access to Information; Independent Investigation. Prior to the execution of this Agreement, the Subscriber has had the opportunity to ask questions of and receive answers from representatives of the Company concerning an investment in the Company, as well as the finances, operations, business and prospects of the Company, and the opportunity to obtain additional information to verify the accuracy of all information so obtained. In determining whether to make this investment, Subscriber has relied solely on Subscriber’s own knowledge and understanding of the Company and its business based upon Subscriber’s own due diligence investigation and the information furnished pursuant to this paragraph. Subscriber understands that no person has been authorized to give any information or to make any representations which were not furnished pursuant to this Section 2 and Subscriber has not relied on any other representations or information in making its investment decision, whether written or oral, relating to the Company, its operations and/or its prospects.

2.1.6. Regulation D Offering. Subscriber represents that it is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”) and acknowledges the sale contemplated hereby is being made in reliance on a private placement exemption to “accredited investors” within the meaning of Section 501(a) of Regulation D under the Securities Act or similar exemptions under state law.

2.1.7. Investment Purposes. The Subscriber is purchasing the Shares solely for investment purposes, for the Subscriber’s own account and not for the account or benefit of any other person, and not with a view towards the distribution or dissemination thereof. The Subscriber did not decide to enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502 under the Securities Act.

2.1.8. Restrictions on Transfer; Shell Company. Subscriber understands the Shares are being offered in a transaction not involving a public offering within the meaning of the Securities Act. Subscriber understands the Shares will be “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, and Subscriber understands that the certificates or book-entries representing the Shares will contain a legend in respect of such restrictions. If in the future the Subscriber decides to offer, resell, pledge or otherwise transfer the Shares, such Shares may be offered, resold, pledged or otherwise transferred only pursuant to: (i) registration under the Securities Act, or (ii) an available exemption from registration. Subscriber agrees that if any transfer of its Shares or any interest therein is proposed to be made, as a condition precedent to any such transfer, Subscriber may be required to deliver to the Company an opinion of counsel satisfactory to the Company. Absent registration or an exemption, the Subscriber agrees not to resell the Shares. Subscriber further acknowledges that because the Company is a shell company, Rule 144 may not be available to the Subscriber for the resale of the Shares until one year following consummation of the initial business combination of the Company, despite technical compliance with the requirements of Rule 144 and the release or waiver of any contractual transfer restrictions.

2.1.9. No Governmental Consents. No governmental, administrative or other third party consents or approvals are required, necessary or appropriate on the part of Subscriber in connection with the transactions contemplated by this Agreement.

2.2. Company’s Representations, Warranties and Agreements. To induce the Subscriber to purchase the Shares, the Company hereby represents and warrants to the Subscriber and agrees with the Subscriber as follows:

2.2.1. Organization and Corporate Power. The Company is a Cayman Islands exempted company and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement.

2.2.2. No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the memorandum and articles of association of the Company, (ii) any agreement, indenture or instrument to which the Company is a party or (iii) any law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree to which the Company is subject.

2.2.3. Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, and upon registration in the register of members of the Company, the Shares will be duly and validly issued as fully paid and non-assessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof, and registration in the Company’s register of members, the Subscriber will have or receive good title to the Shares, free and clear of all liens, claims and encumbrances of any kind, other than (a) transfer restrictions hereunder and other agreements to which the Shares may be subject which have been notified to the Subscriber in writing, (b) transfer restrictions under federal and state securities laws, and (c) liens, claims or encumbrances imposed due to the actions of the Subscriber.

2.2.4. No Adverse Actions. There are no actions, suits, investigations or proceedings pending, threatened against or affecting the Company which: (i) seek to restrain, enjoin, prevent the consummation of or otherwise affect the transactions contemplated by this Agreement or (ii) question the validity or legality of any transactions or seeks to recover damages or to obtain other relief in connection with any transactions.

3. Surrender and Cancellation of Shares.

3.1. Partial or No Exercise of the Over-allotment Option. In the event the Over-allotment Option granted to the underwriters of the IPO is not exercised in full, the Subscriber acknowledges and agrees that it (or, if applicable, it and any transferees of Shares) shall surrender for cancellation any and all rights to such number of Shares (up to an aggregate of 1,607,143 Shares and pro rata based upon the percentage of the Over-allotment Option exercised) such that immediately following such surrender and cancellation, the Subscriber (and all other initial shareholders prior to the IPO, if any) will own an aggregate number of Shares, not including ordinary shares issuable upon exercise of any warrants, rights or any ordinary shares subscribed for and purchased by Subscriber in the IPO or in the aftermarket equal to 30% of the issued and outstanding Shares immediately following the IPO.

3.2. Termination of Rights as Shareholder. If any of the Shares are surrendered and cancelled in accordance with this Section 3, then after such time the Subscriber (or successor in interest), shall no longer have any rights as a holder of such surrendered Shares, and the Company shall take such action as is appropriate to cancel such Shares.

4. Waiver of Liquidation Distributions; Redemption Rights. In connection with the Shares subscribed for and purchased pursuant to this Agreement, the Subscriber hereby waives any and all right, title, interest or claim of any kind in or to any distributions by the Company from the trust account which will be established for the benefit of the Company’s public shareholders and into which substantially all of the proceeds of the IPO will be deposited (the “Trust Account”), in the event of a liquidation of the Company upon the Company’s failure to timely complete an initial business combination. For purposes of clarity, in the event the Subscriber subscribes for and purchases Shares in the IPO or in the aftermarket, any additional Shares so subscribed for and purchased shall be eligible to receive any liquidating distributions by the Company. However, in no event will the Subscriber have the right to redeem any ordinary shares into funds held in the Trust Account upon the successful completion of an initial business combination.

5. Restrictions on Transfer.

5.1. Securities Law Restrictions. In addition to any restrictions to be contained in that certain letter agreement (commonly known as an “Insider Letter”) to be dated as of the closing of the IPO by and between Subscriber and the Company, Subscriber agrees not to sell, transfer, pledge, hypothecate or otherwise dispose of all or any part of the Shares unless, prior thereto (a) a registration statement on the appropriate form under the Securities Act and applicable state securities laws with respect to the Shares proposed to be transferred shall then be effective or (b) the Company has received an opinion from counsel reasonably satisfactory to the Company, that such registration is not required because such transaction is exempt from registration under the Securities Act and the rules promulgated by the Securities and Exchange Commission thereunder and with all applicable state securities laws.

5.2. Lock-up. Subscriber acknowledges that the Securities will be subject to lock-up provisions (the “Lock-up”) contained in the Insider Letter.

5.3. Restrictive Legends. Any certificates representing the Shares shall have endorsed thereon legends substantially as follows:

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL, IS AVAILABLE.”

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCKUP AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF THE LOCKUP.”

5.4. Additional Shares or Substituted Securities. In the event of the declaration of a share capitalisation, the declaration of an extraordinary dividend payable in a form other than Shares, a spin-off, a share sub-division, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding ordinary shares without receipt of consideration, any new, substituted or additional securities or other property which are by reason of such transaction distributed with respect to any Shares subject to this Section 5 or into which such Shares thereby become convertible shall immediately be subject to this Section 5 and Section 3. Appropriate adjustments to reflect the distribution of such securities or property shall be made to the number and/or class of Shares subject to this Section 5 and Section 3.

5.5. Registration Rights. Subscriber acknowledges that the Shares are being subscribed for and purchased pursuant to an exemption from the registration requirements of the Securities Act and will become freely tradable only after certain conditions are met or they are registered pursuant to a registration rights agreement to be entered into with the Company prior to the closing of the IPO.

6. Other Agreements.

6.1. Further Assurances. Subscriber agrees to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

6.2. Notices. All notices, statements or other documents which are required or contemplated by this Agreement shall be: (i) in writing and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party and (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.

6.3. Entire Agreement. This Agreement, together with the Insider Letter and the registration rights agreement, each substantially in the form to be filed as an exhibit to the Registration Statement on Form S-1 associated with the Company’s IPO, embodies the entire agreement and understanding between the Subscriber and the Company with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement of any kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and provisions of this Agreement.

6.4. Modifications and Amendments. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by all parties hereto.

6.5. Waivers and Consents. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by a written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.

6.6. Assignment. The rights and obligations under this Agreement may not be assigned by either party hereto without the prior written consent of the other party.

6.7. Benefit. All statements, representations, warranties, covenants and agreements in this Agreement shall be binding on the parties hereto and shall inure to the benefit of the respective successors and permitted assigns of each party hereto. Nothing in this Agreement shall be construed to create any rights or obligations except among the parties hereto, and no person or entity shall be regarded as a third-party beneficiary of this Agreement.

6.8. Governing Law. This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by the laws of New York applicable to contracts wholly performed within the borders of such state, without giving effect to the conflict of law principles thereof.

6.9. Severability. In the event that any court of competent jurisdiction shall determine that any provision, or any portion thereof, contained in this Agreement shall be unreasonable or unenforceable in any respect, then such provision shall be deemed limited to the extent that such court deems it reasonable and enforceable, and as so limited shall remain in full force and effect. In the event that such court shall deem any such provision, or portion thereof, wholly unenforceable, the remaining provisions of this Agreement shall nevertheless remain in full force and effect.

6.10. No Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under this Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of any such right, power or remedy of such party. No single or partial exercise of any right, power or remedy under this Agreement by a party hereto, nor any abandonment or discontinuance of steps to enforce any such right, power or remedy, shall preclude such party from any other or further exercise thereof or the exercise of any other right, power or remedy hereunder. The election of any remedy by a party hereto shall not constitute a waiver of the right of such party to pursue other available remedies. No notice to or demand on a party not expressly required under this Agreement shall entitle the party receiving such notice or demand to any other or further notice or demand in similar or other circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further action in any circumstances without such notice or demand.

6.11. Survival of Representations and Warranties. All representations and warranties made by the parties hereto in this Agreement or in any other agreement, certificate or instrument provided for or contemplated hereby, shall survive the execution and delivery hereof and any investigations made by or on behalf of the parties.

6.12. No Broker or Finder. Each of the parties hereto represents and warrants to the other that no broker, finder or other financial consultant has acted on its behalf in connection with this Agreement or the transactions contemplated hereby in such a way as to create any liability on the other. Each of the parties hereto agrees to indemnify and save the other harmless from any claim or demand for commission or other compensation by any broker, finder, financial consultant or similar agent claiming to have been employed by or on behalf of such party and to bear the cost of legal expenses incurred in defending against any such claim.

6.13. Headings and Captions. The headings and captions of the various subdivisions of this Agreement are for convenience of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

6.14. Counterparts. This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

6.15. Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant.

6.16. Mutual Drafting. This Agreement is the joint product of the Subscriber and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.

7. Voting and Tender of Shares. Subscriber agrees to vote the Shares in favor of an initial business combination that the Company negotiates and submits for approval to the Company’s shareholders and shall not seek redemption or repurchase with respect to such Shares. Additionally, the Subscriber agrees not to tender any Shares in connection with a tender offer presented to the Company’s shareholders in connection with an initial business combination negotiated by the Company.

8. Indemnification. Each party shall indemnify the other against any loss, cost or damages (including reasonable attorney’s fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or agreement in this Agreement.

[Signature Page Follows]

If the foregoing accurately sets forth our understanding and agreement, please sign the enclosed copy of this Agreement and return it to us.

Very truly yours,
AEON ACQUISITION I CORP.
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	Chief Executive Officer

Accepted and agreed as of the date first written above.
AEON ACQUISITION PARTNERS I LLC
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	Member

[Signature Page to Securities Subscription Agreement]

EX-10.2

Exhibit 10.2

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

PROMISSORY NOTE

Principal Amount: $200,000.00 Dated as of August 20, 2025

Aeon Acquisition I Corp., a Cayman Islands exempted company (the “Maker”), promises to pay to the order of Aeon Acquisition Partners I LLC, its registered assigns or successors in interest (the “Payee”), the principal sum of Two Hundred Thousand Dollars ($200,000) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.

1. Principal. The principal balance of this Promissory Note (this “Note”) shall be payable promptly after the date on which the Maker consummates an initial public offering of its securities or the date on which the Company determines not to conduct an initial public offering of its securities. The principal balance may be prepaid at any time.

2. Interest. No interest shall accrue on the unpaid principal balance of this Note.

3. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

4. Events of Default. The following shall constitute an event of default (“Event of Default”):

(a) Failure to Make Required Payments. Failure by Maker to pay the principal of this Note within five (5) business days following the date when due.

(b) Voluntary Liquidation, Etc. The commencement by Maker of a proceeding relating to its bankruptcy, insolvency, reorganization, rehabilitation or other similar action, or the consent by it to the appointment of, or taking possession by, a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) for Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

(c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of maker in an involuntary case under any applicable bankruptcy, insolvency or similar law, for the appointing of a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) for Maker or for any substantial part of its property, or ordering the winding-up or liquidation of the affairs of Maker, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

5. Remedies.

(a) Upon the occurrence of an Event of Default specified in Section 4(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

(b) Upon the occurrence of an Event of Default specified in Sections 4(b) and 4(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

1

6. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

7.

Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

8.

Notices. Any notice called for hereunder shall be deemed properly given if (i) sent by certified mail, return receipt requested, (ii) personally delivered, (iii) dispatched by any form of private or governmental express mail or delivery service providing receipted delivery or (iv) sent by facsimile or (v) to the following addresses or to such other address as either party may designate by notice in accordance with this Section:

If to Maker:

Aeon Acquisition I Corp.

66 West Flagler Street
Suite 900
Miami, FL 33130

If to Payee:

Aeon Acquisition Partners I LLC

66 West Flagler Street
Suite 900
Miami, FL 33130

Notice shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the date shown on a facsimile transmission confirmation, (iii) the date reflected on a signed delivery receipt, or (iv) two (2) Business Days following tender of delivery or dispatch by express mail or delivery service.

9. Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

10. Jurisdiction. The courts of New York have exclusive jurisdiction to settle any dispute arising out of or in connection with this agreement (including a dispute relating to any non-contractual obligations arising out of or in connection with this agreement) and the parties submit to the exclusive jurisdiction of the courts of New York.

11. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

2

12. Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any amounts contained in the trust account in which the proceeds of the initial public offering (the “IPO”) conducted by the Maker and the proceeds of the sale of securities in a private placement to occur prior to the effectiveness of the IPO, as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, will be placed, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim from the trust account or any distribution therefrom for any reason whatsoever.

13.	Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.
14.	Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.

15. Further Assurance. The Maker shall, at its own cost and expense, execute and do (or procure to be executed and done by any other necessary party) all such deeds, documents, acts and things as the Payee may from time to time require as may be necessary to give full effect to this Promissory Note.

IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed on the day and year first above written.

AEON ACQUISITION I CORP.
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	CEO

3

EX-10.3

Exhibit 10.3

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

PROMISSORY NOTE

Principal Amount: $350,000.00 Dated as of December [    ], 2025

This Note amends and restates that certain promissory note dated August 20, 2025, by and between Aeon Acquisition I Corp., a Cayman Islands exempted company (the “Maker”) and Aeon Acquisition Partners I LLC, its registered assigns or successors in interest (the “Payee”). The Maker promises to pay to the order of the Payee the principal sum of Three Hundred and Fifty Thousand Dollars ($350,000) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.

1. Principal. The principal balance of this Promissory Note (this “Note”) shall be payable promptly after the date on which the Maker consummates an initial public offering of its securities or the date on which the Company determines not to conduct an initial public offering of its securities. The principal balance may be prepaid at any time.

2. Interest. No interest shall accrue on the unpaid principal balance of this Note.

3. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

4. Events of Default. The following shall constitute an event of default (“Event of Default”):

(a) Failure to Make Required Payments. Failure by Maker to pay the principal of this Note within five (5) business days following the date when due.

(b) Voluntary Liquidation, Etc. The commencement by Maker of a proceeding relating to its bankruptcy, insolvency, reorganization, rehabilitation or other similar action, or the consent by it to the appointment of, or taking possession by, a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) for Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

(c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of maker in an involuntary case under any applicable bankruptcy, insolvency or similar law, for the appointing of a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) for Maker or for any substantial part of its property, or ordering the winding-up or liquidation of the affairs of Maker, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

5. Remedies.

(a) Upon the occurrence of an Event of Default specified in Section 4(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

(b) Upon the occurrence of an Event of Default specified in Sections 4(b) and 4(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

1

6. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

7.

Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

8.

Notices. Any notice called for hereunder shall be deemed properly given if (i) sent by certified mail, return receipt requested, (ii) personally delivered, (iii) dispatched by any form of private or governmental express mail or delivery service providing receipted delivery or (iv) sent by facsimile or (v) to the following addresses or to such other address as either party may designate by notice in accordance with this Section:

If to Maker:

Aeon Acquisition I Corp.

66 West Flagler Street
Suite 900
Miami, FL 33130

If to Payee:

Aeon Acquisition Partners I LLC

66 West Flagler Street
Suite 900
Miami, FL 33130

Notice shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the date shown on a facsimile transmission confirmation, (iii) the date reflected on a signed delivery receipt, or (iv) two (2) Business Days following tender of delivery or dispatch by express mail or delivery service.

9. Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

10. Jurisdiction. The courts of New York have exclusive jurisdiction to settle any dispute arising out of or in connection with this agreement (including a dispute relating to any non-contractual obligations arising out of or in connection with this agreement) and the parties submit to the exclusive jurisdiction of the courts of New York.

11. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

2

12. Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any amounts contained in the trust account in which the proceeds of the initial public offering (the “IPO”) conducted by the Maker and the proceeds of the sale of securities in a private placement to occur prior to the effectiveness of the IPO, as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, will be placed, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim from the trust account or any distribution therefrom for any reason whatsoever.

13.	Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.
14.	Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.

15. Further Assurance. The Maker shall, at its own cost and expense, execute and do (or procure to be executed and done by any other necessary party) all such deeds, documents, acts and things as the Payee may from time to time require as may be necessary to give full effect to this Promissory Note.

IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed on the day and year first above written.

AEON ACQUISITION I CORP.
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	CEO

3

EX-10.4

Exhibit 10.4

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

SECOND AMENDED AND RESTATED
PROMISSORY NOTE

Principal Amount: $450,000.00 Dated as of February 12, 2026

This Note further amends and restates that certain promissory note, originally dated August 20, 2025, by and between Aeon Acquisition I Corp., a Cayman Islands exempted company (the “Maker”) and Aeon Acquisition Partners I LLC, its registered assigns or successors in interest (the “Payee”). The Maker promises to pay to the order of the Payee the principal sum of Four Hundred and Fifty Thousand Dollars ($450,000) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.

1. Principal. The principal balance of this Promissory Note (this “Note”) shall be payable promptly after the date on which the Maker consummates an initial public offering of its securities or the date on which the Company determines not to conduct an initial public offering of its securities. The principal balance may be prepaid at any time.

2. Interest. No interest shall accrue on the unpaid principal balance of this Note.

3. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

4. Events of Default. The following shall constitute an event of default (“Event of Default”):

(a) Failure to Make Required Payments. Failure by Maker to pay the principal of this Note within five (5) business days following the date when due.

(b) Voluntary Liquidation, Etc. The commencement by Maker of a proceeding relating to its bankruptcy, insolvency, reorganization, rehabilitation or other similar action, or the consent by it to the appointment of, or taking possession by, a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) for Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

(c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of maker in an involuntary case under any applicable bankruptcy, insolvency or similar law, for the appointing of a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) for Maker or for any substantial part of its property, or ordering the winding-up or liquidation of the affairs of Maker, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

5. Remedies.

(a) Upon the occurrence of an Event of Default specified in Section 4(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

(b) Upon the occurrence of an Event of Default specified in Sections 4(b) and 4(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

1

6. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

7.

Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

8.

Notices. Any notice called for hereunder shall be deemed properly given if (i) sent by certified mail, return receipt requested, (ii) personally delivered, (iii) dispatched by any form of private or governmental express mail or delivery service providing receipted delivery or (iv) sent by facsimile or (v) to the following addresses or to such other address as either party may designate by notice in accordance with this Section:

If to Maker:

Aeon Acquisition I Corp.

66 West Flagler Street

Suite 900

Miami, FL 33130

If to Payee:

Aeon Acquisition Partners I LLC

66 West Flagler Street

Suite 900

Miami, FL 33130

Notice shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the date shown on a facsimile transmission confirmation, (iii) the date reflected on a signed delivery receipt, or (iv) two (2) Business Days following tender of delivery or dispatch by express mail or delivery service.

9. Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

10. Jurisdiction. The courts of New York have exclusive jurisdiction to settle any dispute arising out of or in connection with this agreement (including a dispute relating to any non-contractual obligations arising out of or in connection with this agreement) and the parties submit to the exclusive jurisdiction of the courts of New York.

11. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

2

12. Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any amounts contained in the trust account in which the proceeds of the initial public offering (the “IPO”) conducted by the Maker and the proceeds of the sale of securities in a private placement to occur prior to the effectiveness of the IPO, as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, will be placed, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim from the trust account or any distribution therefrom for any reason whatsoever.

13.	Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.
14.	Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.

15. Further Assurance. The Maker shall, at its own cost and expense, execute and do (or procure to be executed and done by any other necessary party) all such deeds, documents, acts and things as the Payee may from time to time require as may be necessary to give full effect to this Promissory Note.

IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed on the day and year first above written.

AEON ACQUISITION I CORP.
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	CEO

3

EX-10.5

Exhibit 10.5

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

THIRD AMENDED AND RESTATED
PROMISSORY NOTE

Principal Amount: $550,000.00 Dated as of April 7, 2026

This Note further amends and restates that certain promissory note, originally dated August 20, 2025, by and between Aeon Acquisition I Corp., a Cayman Islands exempted company (the “Maker”) and Aeon Acquisition Partners I LLC, its registered assigns or successors in interest (the “Payee”). The Maker promises to pay to the order of the Payee the principal sum of Five Hundred and Fifty Thousand Dollars ($550,000) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.

1. Principal. The principal balance of this Promissory Note (this “Note”) shall be payable promptly after the date on which the Maker consummates an initial public offering of its securities or the date on which the Company determines not to conduct an initial public offering of its securities. The principal balance may be prepaid at any time.

2. Interest. No interest shall accrue on the unpaid principal balance of this Note.

3. Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

4. Events of Default. The following shall constitute an event of default (“Event of Default”):

(a) Failure to Make Required Payments. Failure by Maker to pay the principal of this Note within five (5) business days following the date when due.

(b) Voluntary Liquidation, Etc. The commencement by Maker of a proceeding relating to its bankruptcy, insolvency, reorganization, rehabilitation or other similar action, or the consent by it to the appointment of, or taking possession by, a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) for Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

(c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of maker in an involuntary case under any applicable bankruptcy, insolvency or similar law, for the appointing of a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) for Maker or for any substantial part of its property, or ordering the winding-up or liquidation of the affairs of Maker, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

5. Remedies.

(a) Upon the occurrence of an Event of Default specified in Section 4(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

(b) Upon the occurrence of an Event of Default specified in Sections 4(b) and 4(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

1

6. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

7.

Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

8.

Notices. Any notice called for hereunder shall be deemed properly given if (i) sent by certified mail, return receipt requested, (ii) personally delivered, (iii) dispatched by any form of private or governmental express mail or delivery service providing receipted delivery or (iv) sent by facsimile or (v) to the following addresses or to such other address as either party may designate by notice in accordance with this Section:

If to Maker:

Aeon Acquisition I Corp.

66 West Flagler Street
Suite 900
Miami, FL 33130

If to Payee:

Aeon Acquisition Partners I LLC

66 West Flagler Street
Suite 900
Miami, FL 33130

Notice shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the date shown on a facsimile transmission confirmation, (iii) the date reflected on a signed delivery receipt, or (iv) two (2) Business Days following tender of delivery or dispatch by express mail or delivery service.

9. Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

10. Jurisdiction. The courts of New York have exclusive jurisdiction to settle any dispute arising out of or in connection with this agreement (including a dispute relating to any non-contractual obligations arising out of or in connection with this agreement) and the parties submit to the exclusive jurisdiction of the courts of New York.

11. Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

2

12. Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any amounts contained in the trust account in which the proceeds of the initial public offering (the “IPO”) conducted by the Maker and the proceeds of the sale of securities in a private placement to occur prior to the effectiveness of the IPO, as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, will be placed, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim from the trust account or any distribution therefrom for any reason whatsoever.

13.	Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.
14.	Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.

15. Further Assurance. The Maker shall, at its own cost and expense, execute and do (or procure to be executed and done by any other necessary party) all such deeds, documents, acts and things as the Payee may from time to time require as may be necessary to give full effect to this Promissory Note.

IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed on the day and year first above written.

AEON ACQUISITION I CORP.
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	CEO

3

EX-10.6

Exhibit 10.6

Indemnification Agreement

This Indemnification Agreement (this “Agreement”) is entered into as of January 29, 2026, by and between Demetrios Mallios and The Aeon Group, Inc. (together, the “Indemnitors”) and Aeon Acquisition I Corp., a Cayman Islands exempted company (“Company”), for the benefit of the Company and its shareholders.

Whereas, the Company received a demand letter from a certain investment bank (the “Investment Bank”) asserting entitlement to certain fees and relief under an engagement letter and related amendment, and referencing potential claims with respect to the Company and its affiliates (the “Investment Bank Matter”);

Whereas, the Indemnitors include the Chairman and Chief Executive Officer of the Company and his affiliate, The Aeon Group, Inc. both of whom desire to jointly and severally indemnify the Company and its shareholders against any liabilities arising out of or relating to the Investment Bank Matter;

Now, therefore, in consideration of the premises and the mutual covenants contained herein, the parties agree as follows:

1. Indemnification

1.1. Indemnification Obligation. The Indemnitors hereby jointly and severally agree to indemnify, defend, and hold harmless the Company (including, but not limited to, the trust account of the Company), its shareholders and each of their respective successors and assigns (the “Indemnified Parties”) to the fullest extent permitted by law, from and against any and all losses, claims, damages, liabilities, judgments, settlements, costs, and expenses of any kind whatsoever (including, without limitation, all reasonable attorneys’ fees, experts’ fees, investigation costs, and other expenses incurred in connection with defending, investigating, settling, or otherwise responding to any claim pursuant to the Indemnification Procedure section in this Agreement) (“Losses”), whether direct or indirect, joint or several, absolute or contingent, arising out of, relating to, or resulting from the Investment Bank Matter, including, without limitation, any demands, claims, arbitration, litigation, or other proceedings brought or threatened by the Investment Bank or any related party based on the engagement letter, amendment, or related transactions.

1.2. Indemnification Procedure.

a. Notice. With respect to any matter for which indemnification is claimed, the Indemnified Parties shall notify the Indemnitors promptly after becoming aware of such matter. A failure or delay to promptly notify the Indemnitors will only relieve the Indemnitors of their obligation to the extent, if at all, that the Indemnitors are prejudiced by reason of such failure or delay.

b. Defense of Claim. Promptly after receipt of any notice pursuant to this Indemnification Procedure section the Indemnitors shall defend, contest, settle, compromise or otherwise protect the Indemnified Parties against any such Losses at Indemnitors’ own cost and expense. Each Indemnified Party will have the right, but not the obligation, to participate, at its own cost and expense, in the defense by counsel of its own choosing; provided, however, that the Indemnitors will be entitled to control the defense unless the Indemnified Party or Parties has or have relieved the Indemnitors in writing from liability with respect to the particular matter. The Indemnified Parties shall reasonably cooperate with the Indemnitors’ requests concerning the defense and contest of any Losses.

c. Failure to Defend. If the Indemnitors do not timely defend, contest or otherwise protect against any Losses after receipt of the required notice, the Indemnified Party or Parties shall have the right, but not the obligation, to defend, contest or otherwise protect against the same, make any compromise or settlement thereof, and recover the entire cost thereof from the Indemnitors, including, without limitation, reasonable attorneys’ fees, disbursements and all amounts paid as a result of such suit, action, investigation and or Losses.

d. Fees and Costs of Defense. Indemnitors shall pay, as they become due, all costs and expenses of the defense and contest, including all attorneys’ fees, experts’ fees, accountants’ fees and the cost of any bond required by law to be posted in connection with the defense or contest except if the Indemnified Party or Parties have relieved Indemnitors from liability with respect to the matter, the Indemnified Party or Parties have exercised their right to participate at their own cost and expense and as otherwise stated in this Agreement.

e. Conclusion of Matter. If Indemnitors elect to defend or contest any Losses, demand, assertion, or claim, Indemnitors shall not be obligated to make any payments to the Indemnified Parties with respect to the matter until the legal remedies available to Indemnitors or the Indemnified Parties, as the case may be, with respect to the matter shall have been exhausted (including appeals).

f. Counterclaims and More. If requested by Indemnitors, the Indemnified Parties shall cooperate with Indemnitors in defending and or contesting any matter that Indemnitors elect to defend and or contest and or, if appropriate, in the making of any counterclaim, crossclaim, third-party-complaint or other affirmative claim. Indemnitors shall reimburse the Indemnified Parties for any reasonable expenses reasonably incurred by the Indemnified Parties in cooperating with Indemnitors. If any counterclaim, crossclaim, third-party-complaint or other affirmative claim results in the receipt by Indemnitors and or the Indemnified Party or Parties of amounts in excess of the amount that is subject to the Losses, demand, assertion, or claim, the excess shall first be applied to the payment of the reasonable costs and expenses of the Indemnified Parties, then Indemnitors, incurred in connection with the defense, contest, counterclaim, crossclaim, third-party-complaint and or other affirmative claims, and the balance shall be retained by Indemnitors.

2

1.3. Scope. This indemnification is intended to be broad and shall apply to any Losses arising at any time, regardless of whether the underlying events occurred before or after the execution of this Agreement. The indemnification obligations set forth herein shall survive any termination of either Indemnitor’s relationship with the Company, the completion of any related transaction, and the termination or expiration of this Agreement.

1.4 No Limitation. The rights of the Indemnified Parties under this Agreement shall be in addition to any other rights to indemnification or contribution that such parties may have by law, contract, or otherwise, and nothing herein shall be deemed to limit or restrict any such rights.

2. Miscellaneous

2.1. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to its conflicts of law principles.

2.2. Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral or written.

2.3. Amendments. This Agreement may not be amended except in writing signed by all parties.

2.4. Assignment. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party, except that the benefit of indemnification may be assigned to the shareholders of the Company.

3

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

Aeon Acquisition I Corp.
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	Chief Executive Officer

The Aeon Group, Inc.
By:	/s/ Demetrios Mallios
Name:	Demetrios Mallios
Title:	Authorized Signatory
/s/ Demetrios Mallios
Demetrios Mallios

4

EX-10.7

Exhibit 10.7

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

SETTLEMENT AGREEMENT

This Settlement Agreement (the “Agreement”) is made, as of March 25, 2026 (the “Execution Date”), by and among Chardan Capital Markets, LLC (“Chardan”), Demetrios Mallios (“Mallios”), individually and on behalf of Geneships Acquisition Corp. (“Geneships”), Aeon Group, Inc. (“AGI”), Aeon Acquisition I Corp. (“Aeon Acquisition”), (collectively, Mallios, AGI, Aeon Acquisition, and Geneships are referred to herein as the “Aeon Parties”), and D. Boral Capital LLC (“DBC”). Each party to this Agreement may be referred to individually as a “Party” and collectively as the “Parties.”

RECITALS

WHEREAS, Chardan, Mallios, individually and on behalf of a to-be-formed special purpose acquisition company, Geneships Acquisition Corp. (“Geneships”), and on behalf of a to-be-formed Sponsor entity, are parties to an engagement letter dated as of September 27, 2023 for a Risk Capital Raise (the “Risk Capital Engagement Letter”); and

WHEREAS, Chardan, Mallios, individually, and on behalf of Geneships, and on behalf of a to-be-formed Sponsor entity, are parties to an engagement letter dated as of September 27, 2023 for a proposed public offering of units in a to-be-formed special purpose acquisition company (the “Engagement Letter”); and

WHEREAS, Chardan, AGI, and a to-be-formed Sponsor entity are parties to a letter agreement dated February 27, 2024, which amends the Engagement Letter (the “Amendment”); and

WHEREAS, on or about February 9, 2026, Chardan filed a Demand for Arbitration with the American Arbitration Association (“AAA”), under Case No. 01-26-0000-6229, and thereby commenced an arbitration proceeding against Mallios, AGI, Aeon Acquisition, and Geneships (the “Arbitration”); and

WHEREAS, on February 24, 2026, Mallios and AGI filed their Answering Statement in the Arbitration, in which they denied all the material allegations in Chardan’s Demand for Arbitration and asserted a counterclaim against Chardan (the “Counterclaim”); and

WHEREAS, on February 23, 2026, Aeon Acquisition commenced a special proceeding (the “Special Proceeding”) in the Supreme Court of the State of New York, New York County (the “Court”), styled Aeon Acquisition I Corp., Petitioner, against Chardan Capital Markets, LLC, Respondent, Index No. 65082/2026, by filing a petition (the “Petition”) seeking to permanently stay the Arbitration as against Aeon Acquisition; and

WHEREAS, the Parties executed by email confirmation a binding settlement term sheet (the “Binding Term Sheet”) on Friday, March 20, 2026, which shall remain binding unless and until the Effective Time (as defined below).

Page 1 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

WHEREAS, each of Chardan and DBC will perform bona fide underwriting services in connection with the IPO consistent with its role as a joint book-running manager, including without limitation participation in due diligence, preparation of the registration statement, investor education and marketing, book-building, pricing, and stabilization activities, and the compensation allocated to each pursuant to this Agreement is intended to be consistent with the requirements of FINRA Rule 5110;

WHEREAS, the Parties acknowledge that the terms of this Agreement, including the underwriting arrangement described herein, may be required to be disclosed in a registration statement, prospectus, and related filings with the United States Securities and Exchange Commission (the “Commission”), the Financial Industry Regulatory Authority (“FINRA”), and any other applicable self-regulatory organization or regulatory authority, and each Party agrees to cooperate fully in connection with any such disclosure obligations; and

WHEREAS, to avoid the expense and uncertainty of further proceedings, the Parties wish to forever resolve and settle their disputes with one another (including without limitation the claims and counterclaims that are or could have been asserted in the Arbitration and/or the Special Proceeding), without any admission of wrongdoing or liability by any Party, upon, and subject to, the terms and conditions set forth herein;

AGREEMENT

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is acknowledged by each of the Parties, it is hereby agreed, by and among the Parties, as follows:

1. Recitals

The Recitals set forth above are incorporated herein and made a part hereof as though set forth at length herein.

2. Defined Terms

(a) “IPO Engagement Letter” means that certain IPO Engagement Letter entered into on [ ], 2026, by and among Aeon Acquisition, Chardan, and DBC.

(b) “Legacy Agreements” means the Risk Capital Engagement Letter, the Engagement Letter, the Amendment and the Binding Term Sheet.

(c) “Underwriting Agreement” means that certain Underwriting Agreement substantially in the form attached as Exhibit 1 hereto, to be entered into on or about the pricing of the initial public offering of units of Aeon Acquisition (the “IPO”), by and among Aeon Acquisition, Chardan, as lead underwriter, and DBC, as co-lead underwriter, together as and co-lead representatives of the several underwriters named on Schedule 1 therein.

(d) “Effective Time” means the time of the closing of the IPO, as defined herein.

Page 2 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

3. Effective Time

This Agreement is contingent, and shall only become effective, upon the consummation of the IPO (the “Effective Time”). Until the Effective Time, no Party shall have any rights or obligations hereunder other than covenants expressly stated herein to be operative prior to the Effective Time, including without limitation the Standstill obligations set forth in Section 23 and the disclosure cooperation obligations set forth in Section 19.

4. Long-Stop Date

If the IPO has not occurred by 4:00 p.m. Eastern Time on the sixtieth (60th) calendar day following the date on which this Agreement has been fully executed by all Parties, subject to extension upon the written agreement of Chardan, D. Boral, and Aeon Acquisition, (the “Long-Stop Date”), this Agreement shall automatically terminate and be of no force or effect, except that Sections 13, 19, 20, 21, 22, 24, 25, 26, and 27 shall survive such termination in accordance with their terms. The Parties acknowledge that the Long-Stop Date and the termination risk associated therewith constitute material information that may be required to be disclosed in the registration statement and prospectus for the IPO.

5. Underwriting of IPO

Chardan will serve as lead underwriter and DBC will serve as co-lead underwriter for the IPO. Chardan will appear first on the cover of any prospectus or preliminary prospectus, and DBC will appear second. Chardan will serve as lead representative of the several underwriters in the Underwriting Agreement, and DBC will serve as co-lead representative. Chardan and DBC will be collectively identified as “Representatives” of the underwriters in the Underwriting Agreement. Chardan and DBC agree that Paul Hastings shall be identified as “lead” underwriter counsel in connection with the IPO and shall be located on the cover in the manner to reflect its role as lead underwriter counsel.

6. Underwriting Fees

(a) Scope of Shared Compensation - Broad Definition

All compensation, remuneration, or consideration of any kind, whether direct or indirect, cash or non-cash, paid, payable, promised, or conveyed to Chardan, DBC or any of their respective affiliates, employees, principals, agents, or designees, in connection with or arising out of the IPO or any transaction contemplated by this Agreement or the Underwriting Agreement - including without limitation:

(i) upfront cash underwriting commissions or discounts;

(ii) overallotment (greenshoe) commissions;

Page 3 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(iii) deferred underwriting fees, whether held in escrow (excluding the SPAC’s trust) or otherwise;

(iv) expense reimbursements of any kind due to underwriters (beyond the $180,000 in legal fees represented in Section 7);

(v) tail compensation or transaction fees payable following the IPO in connection with any business combination that would be due to the underwriters;

(vi) any economic benefit associated with the Right of First Refusal; and

(vii) any other compensation, consideration, or thing of value, however characterized or structured, that would constitute “underwriting compensation” as defined under FINRA Rule 5110 or that is paid in connection with or as a result of the IPO -

shall constitute “Total IPO Compensation” for purposes of this Agreement and shall be subject to the 50/50 allocation between Chardan and DBC set forth in Section 6(b). Notwithstanding anything to the contrary in this Section 6 or elsewhere in this Agreement, Section 6 and any compensation, fee, reimbursement, right, preference, or other economic benefit contemplated hereby shall be interpreted, applied, and automatically limited in a manner consistent with applicable law and FINRA Rule 5110, and no Party shall be entitled to receive, and no other Party shall be required to pay or provide, any compensation, fee, reimbursement, right, preference, or other economic benefit to the extent prohibited thereby. To the extent any provision of this Section 6 would otherwise result in compensation or another economic benefit in excess of that permitted by applicable law or FINRA Rule 5110, such provision shall be deemed modified solely to the minimum extent necessary to render it compliant.

(b) 50/50 Allocation; Payment Mechanics

All Total IPO Compensation shall be allocated fifty percent (50%) to Chardan and fifty percent (50%) to DBC with both Chardan and DBC being paid directly from the flow of funds. To the extent any excess (based on the allocation above) Total IPO Compensation is paid or payable directly to DBC or Chardan (rather than jointly to Chardan and DBC), either DBC or Chardan shall hold the other’s fifty percent (50%) share in trust and shall remit such share to Chardan or DBC within three (3) business days of receipt. Neither Chardan, DBC nor any Aeon Party shall direct or instruct any payor to route compensation in a manner designed to circumvent the 50/50 allocation. For the avoidance of doubt, as between Chardan and DBC only, any underwriting compensation payable to them in connection with the IPO under the definitive underwriting documents shall be allocated fifty percent (50%) to Chardan and fifty percent (50%) to DBC, irrespective of the internal allocation of orders, sales credit, or participation credit between them. To the extent necessary to effect that allocation, any equalization payments shall be made solely between Chardan and DBC. This split shall not increase or otherwise modify the amount of underwriting compensation payable by Aeon Acquisition, and neither Aeon Acquisition nor its trust account shall have any responsibility for or fund any payment required to effect that split.

Page 4 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(c) No Side Arrangements.

Each of Chardan, DBC and the Aeon Parties represents, warrants, and covenants that:

(i) as of the date of this Agreement, there are no side letters, side agreements, oral agreements, fee arrangements, compensation arrangements, or understandings of any kind between or among any of them (or their respective affiliates, employees, or agents) relating to underwriter compensation related to the IPO that is not disclosed in the S-1;

(ii) from the date of this Agreement through 24 months following the Effective Time, none of Chardan, DBC, AGI, Aeon Acquisition, Mallios, or any of their respective affiliates shall enter into any side letter, side agreement, or other arrangement that would have the effect of compensating Chardan or DBC or any of their affiliates in connection with the IPO outside of the Total IPO Compensation framework set forth in this Section 6; and

(iii) any arrangement described in clause (ii) entered into without DBC’s and Chardan’s prior written consent shall be void and unenforceable, and any compensation received thereunder shall be deemed Total IPO Compensation subject to the 50/50 allocation, regardless of how it is characterized; and

For the avoidance of doubt, any compensation, payment, fee, commission, rebate, profit interest, equity or equity-linked security, or other thing of value that is paid or delivered, directly or indirectly, to any spouse, domestic partner, immediate family member, or other Person acting for the benefit of any officer, director, employee, principal, or owner of Chardan and/or DBC, in connection with or arising out of the IPO or any transaction contemplated by this Agreement in Section 6 or the Underwriting Agreement, shall be deemed Total IPO Compensation for purposes of this Section 6, regardless of the name or account in which such compensation is held or recorded.

(d) Disclosure

Chardan and DBC shall promptly certify in writing to one another any compensation, payment, or thing of value received by Chardan or DBC, or any of each of their affiliates, in connection with the IPO or another transaction that is a “Subject Transaction” pursuant to the Underwriting Agreement, whether or not Chardan or DBC believe it constitutes Total IPO Compensation.

(e) FINRA Rule 5110 Compliance

The Parties acknowledge and agree that all Total IPO Compensation is subject to review and approval by FINRA pursuant to FINRA Rule 5110, and that the Underwriting Agreement shall contain terms consistent therewith, including: (i) compliance with the aggregate underwriting compensation cap of Rule 5110(b)(2)(C); (ii) 180-day lock-up restrictions on representative shares or similar securities per Rule 5110(e)(1); and (iii) full itemization of all compensation items in the FINRA Rule 5110 filing, to be submitted no later than three (3) business days after the related registration statement (or any amendment thereto) is filed with the Commission. In the event FINRA requires any modification to the compensation structure, the Parties shall negotiate in good faith to implement such modifications in a manner that preserves, to the extent permissible, the 50/50 economic allocation.

Page 5 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(f) Breach; Remedies

Any breach of this Section 6, including without limitation any failure to disclose compensation, any violation of the no-side-arrangements covenant, any failure to remit DBC’s or Chardan’s share of Total IPO Compensation, or any circumvention of the 50/50 allocation, shall constitute a material breach of this Agreement entitling the aggrieved party, to: (i) recover all amounts wrongfully withheld or diverted, with interest at the statutory rate from the date due; (ii) seek specific performance of the compensation obligations hereunder; (iii) recover its reasonable attorneys’ fees and costs in connection with any enforcement action; and (iv) seek any other remedies available at law or in equity. The Parties agree that monetary damages alone may be inadequate to remedy a breach of this Section and that equitable relief shall be available without the requirement to post a bond.

(g) Each of Chardan and DBC represents and warrants that neither it nor any of its affiliates, employees, or principals holds, has been promised, or will receive any founder shares, sponsor equity, private placement warrants, or private placement units in Aeon Acquisition or its Sponsor in connection with the IPO. Any such interest, if received, shall be deemed Total IPO Compensation and included in the FINRA Rule 5110 filing.

7. Underwriting Expenses

DBC represents to Chardan that, as of the date of this Agreement, DBC, as underwriter, has not incurred any expenses beyond legal fees of $180,000. Notwithstanding the foregoing, Chardan and DBC have executed an engagement letter with Paul Hastings that provides that the total amount charged by Paul Hastings can, under specified circumstances, exceed $180,000. DBC represents and warrants that this representation is true, complete, and not misleading as of the date hereof. DBC shall promptly notify Chardan in writing if it becomes aware that this representation was inaccurate as of the date made or becomes inaccurate prior to the Effective Time. DBC and Chardan shall cooperate to minimize clearing, net capital, and other deal-related expenses to be incurred in connection with the IPO.

8. Right of First Refusal

(a) Chardan and DBC will share equally (50/50) in the economic benefit of the right of first refusal agreed to by Aeon Acquisition in the Underwriting Agreement (the “Right of First Refusal”). The Right of First Refusal shall be subject to the limitations set forth in FINRA Rule 5110(g)(5)(B), including that: (i) its duration shall not exceed three (3) years from the effective date of the registration statement for the IPO; and (ii) its terms shall not be unreasonably burdensome to Aeon Acquisition. For the avoidance of doubt, the applicable duration of the Right of First Refusal, if any, shall be as contained within the Underwriting Agreement.

Page 6 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(b) The Right of First Refusal shall apply only to Aeon Acquisition I Corp (ticker AESPU, as amended, and sometimes referred to elsewhere as Aeon SPAC1-Sports), any successor thereto, and any of its or their controlled affiliates, but not to any non-controlled affiliates of Aeon Acquisition or Mallios, or any other affiliates of Mallios, including without limitation The Aeon Group, Inc.

(c) The Parties acknowledge that the Right of First Refusal and its economic value must be disclosed in the registration statement and prospectus, including a good-faith estimate of its value to the extent required by FINRA or the Commission.

9. Discontinuance of Arbitration and Special Proceeding

Within three (3) business days after the Effective Time, the Parties shall cause their respective attorneys to file stipulations of dismissal with prejudice with the AAA and with the Court, terminating the Arbitration and the Special Proceeding, respectively. Prior to the Effective Time, the Parties shall not take any action to advance, escalate, or seek substantive relief in the Arbitration or the Special Proceeding.

10. Termination of Legacy Agreements

Upon the Effective Time, the Legacy Agreements shall automatically terminate and be deemed null, void, unenforceable, and of no further force or effect, without further action by any Party. No party to the Legacy Agreements shall have any further rights or obligations with respect to any other party pursuant to the Legacy Agreements, or any of them. For the avoidance of doubt, the termination of the Legacy Agreements shall not affect any rights or claims arising under such agreements prior to their termination that are not otherwise released pursuant to Section 11 of this Agreement.

11. Mutual Releases

(a) Effective as of the Effective Time, DBC and Chardan, on behalf of themselves and each of their predecessors, successors, assigns, parents, subsidiaries, affiliates, shareholders, partners, members, managers, directors, officers, employees, agents, and representatives (each, a “DBC Releasing Party” or a “Chardan Releasing Party” and collectively, the “DBC and Chardan Releasing Parties”), hereby forever, fully, finally, and irrevocably discharges and releases Mallios, AGI, Aeon Acquisition, and Geneships, together with each of their respective current and former heirs, executors, administrators, predecessors, successors, assigns, parents, subsidiaries, direct or indirect affiliates, shareholders, partners, members, managers, directors, officers, employees, agents, representatives, insurers, accountants, and attorneys, acting in such capacity (each, an “Aeon Released Party”), from all known and unknown charges, complaints, grievances, liabilities, obligations, promises, agreements, contracts, warranties, actions, causes of action, suits, costs, losses, penalties, fees, expenses, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, controversies, variances, trespasses, damages, judgments, extents, executions, rights, claims, and demands of any kind, nature, or description whatsoever, in law, admiralty, or equity, whether contingent or direct, disclosed or undisclosed, known or unknown, which any Chardan Releasing Parties or any DBC Releasing Parties ever had, may have had, now have, or hereafter can, shall, or may have against any Aeon Released Party, for, upon, or by reason of any event, matter, cause, or thing whatsoever, from the beginning of the world to the Execution Date arising out of or relating to any and all acts, omissions, or events occurring on or prior to the Execution Date with any of Aeon Acquisition, AGI, Mallios or any of their affiliates; provided, however, that any agreements executed from and after the Execution Date, including the IPO Engagement Letter and the Underwriting Agreement, and the obligations thereunder, and the monetary obligations under Section 6 of this Agreement shall not be released until fully satisfied.

Page 7 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(b) Effective as of the Effective Time, Mallios, AGI, Aeon Acquisition and Geneships, together with each of their respective heirs, executors, administrators, predecessors, successors, assigns, parents, subsidiaries, affiliates, shareholders, partners, members, managers, directors, officers, employees, agents, representatives, insurers, accountants, and attorneys (each, an “Aeon Releasing Party”), hereby forever, fully, finally, and irrevocably discharges and releases Chardan, and DBC, each of their current and former administrators, predecessors, successors, assigns, parents, subsidiaries, direct and indirect affiliates, shareholders, partners, members, managers, directors, officers, employees, agents, representatives, insurers, accountants, and attorneys, acting in such capacity (each, respectively a “DBC Released Party” and a “Chardan Released Party”), from all known and unknown charges, complaints, grievances, liabilities, obligations, promises, agreements, contracts, warranties, actions, causes of action, suits, costs, losses, penalties, fees, expenses, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, controversies, variances, trespasses, damages, judgments, extents, executions, rights, claims, and demands of any kind, nature, or description whatsoever, in law, admiralty, or equity, whether contingent or direct, disclosed or undisclosed, known or unknown, which the Aeon Releasing Parties ever had, may have had, now have, or hereafter can, shall, or may have against any DBC Released Party or any Chardan Released Party, for, upon, or by reason of any event, matter, cause, or thing whatsoever, from the beginning of the world to the Execution Date; provided, however, that any agreements executed from and after the Execution Date, including the IPO Engagement Letter and the Underwriting Agreement, and the obligations thereunder, and the monetary obligations under Section 6 of this Agreement shall not be released until fully satisfied.

(c) Effective as of the Effective Time, DBC and Chardan, on behalf of themselves and their predecessors, successors, assigns, parents, subsidiaries, affiliates, shareholders, partners, members, managers, directors, officers, employees, agents, and representatives (each, a “DBC Releasing Party” or “Chardan Releasing Party” and collectively, the “DBC and Chardan Releasing Parties”), hereby forever, fully, finally, and irrevocably discharges and releases each other, together with each of their respective current and former heirs, executors, administrators, predecessors, successors, assigns, parents, subsidiaries, direct or indirect affiliates, shareholders, partners, members, managers, directors, officers, employees, agents, representatives, insurers, accountants, and attorneys, acting in such capacity (each, an “DBC Released Party” or a “Chardan Released Party”), from all known and unknown charges, complaints, grievances, liabilities, obligations, promises, agreements, contracts, warranties, actions, causes of action, suits, costs, losses, penalties, fees, expenses, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, controversies, variances, trespasses, damages, judgments, extents, executions, rights, claims, and demands of any kind, nature, or description whatsoever, in law, admiralty, or equity, whether contingent or direct, disclosed or undisclosed, known or unknown, which the DBC Releasing Parties or the Chardan Releasing Parties ever had, may have had, now have, or hereafter can, shall, or may have against any DBC Released Party, or Chardan Released Party for, upon, or by reason of any event, matter, cause, or thing whatsoever, from the beginning of the world to the Execution Date; provided, however, that any agreements executed from and after the Execution Date, including the IPO Engagement Letter and the Underwriting Agreement, and the obligations thereunder, and the monetary obligations under Section 6 of this Agreement shall not be released until fully satisfied.

Page 8 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(c) The foregoing discharges and releases (the “Releases”) shall become effective as of the Effective Time and shall not be effective for any purpose prior thereto.

(d) Notwithstanding anything to the contrary herein, nothing in this Agreement shall release, waive, or otherwise affect any rights, obligations, or liabilities of any Party arising under this Agreement, including, without limitation, any provision relating to performance, enforcement, interpretation, or remedies in respect hereof.

(e) For the avoidance of doubt, neither the Releases nor any other provision of this Agreement shall be construed to limit or impair any Party’s right or obligation to make disclosures required by applicable securities laws, FINRA rules, or Commission regulations, including without limitation any disclosure required in connection with the registration statement or prospectus for the IPO or any subsequent reporting obligations.

12. Representations, Warranties, and Covenants

(a) Aeon Acquisition - Authority; Due Authorization. Aeon Acquisition represents and warrants that it has the full power and authority to enter into this Agreement and give its Release, and that this Agreement has been duly authorized by all necessary corporate action, including approval by its Board of Directors, including approval by its independent directors to the extent required by applicable law or stock exchange listing standards. Aeon Acquisition shall deliver to Chardan, contemporaneously with the execution of this Agreement, a certified copy of the consent or resolution of its Board of Directors evidencing such approval. Aeon Acquisition irrevocably waives any defense based on lack of corporate authority or failure to obtain Board approval with respect to the enforceability of this Agreement.

(b) AGI - Authority; Due Authorization. AGI represents and warrants that it has the full power and authority to enter into this Agreement and give its Release, and that this Agreement has been duly authorized by all necessary corporate action, including approval by its Board of Directors. AGI shall deliver to Chardan, contemporaneously with the execution of this Agreement, a certified copy of the consent or resolution of its Board of Directors evidencing such approval. AGI irrevocably waives any defense based on lack of corporate authority or failure to obtain Board approval with respect to the enforceability of this Agreement.

(c) Mallios, individually and on behalf of Geneships - Authority; Due Authorization. Mallios represents and warrants that he has full power, legal capacity, and authority to enter into this Agreement and to perform his obligations hereunder, and that this Agreement has been duly executed and delivered by him and constitutes his legal, valid, and binding obligation, enforceable against him in accordance with its terms, on his individual behalf and on behalf of Geneships.

(d) Individual Signatories. Each individual executing this Agreement on behalf of a Party represents and warrants that he or she has full authority to execute and deliver this Agreement on behalf of such Party and to bind such Party thereby.

(e) No Conflicts. Each of Chardan, Aeon Acquisition, AGI, Geneships, and DBC represents and warrants that the execution, delivery, and performance of this Agreement do not and will not: (i) violate any provision of its organizational documents; (ii) conflict with or result in a breach of any material agreement, instrument, or obligation to which it is a party or by which it or its assets are bound; or (iii) violate any applicable law, rule, or regulation, or any order, judgment, or decree applicable to it.

(f) No Reliance; Independent Judgment. Each Party expressly disclaims reliance upon, and acknowledges that, except as expressly set forth in this Agreement, it has not relied upon, any oral or written agreement, promise, understanding, representation, or warranty of any other Party in entering into this Agreement; provided, however, that nothing in this Agreement shall limit or waive any claims arising out of or relating to fraud, fraudulent inducement, intentional misrepresentation, or the knowing concealment or nondisclosure of material facts.

(g) No Fraud; No Concealment. Each Party represents and warrants that neither it nor any of its Released Parties has engaged in any fraud, fraudulent inducement, intentional misrepresentation, or the knowing concealment or nondisclosure of any material fact in connection with the negotiation or execution of this Agreement.

Page 9 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(h) FINRA Membership; Regulatory Standing. Each of Chardan and DBC represents and warrants that, as of the date of this Agreement and as of the Effective Time: (i) it is a duly registered broker-dealer and member in good standing of FINRA; (ii) it has no pending disciplinary proceedings that would materially impair its ability to serve as underwriter in the IPO; and (iii) it will promptly notify the other Parties if any event occurs prior to the Effective Time that would cause this representation to be untrue.

(i) Covenant to Cooperate. Each Party agrees to execute and deliver such additional documents and to take such further actions as may be reasonably necessary to carry out the purposes and intent of this Agreement, including without limitation cooperating in connection with FINRA Rule 5110 filings, Commission comment responses, and any regulatory inquiries relating to the IPO.

(j) No Assignment. Each Party represents and warrants that it has not assigned or transferred, or purported to assign or transfer, any claim, right, or interest released or affected by this Agreement.

(k) Survival of Representations and Warranties. The representations and warranties set forth in this Section 12 shall survive the execution of this Agreement and the Effective Time for a period of three (3) years following the Effective Time, except that representations identified as relating to authority, due authorization, and the absence of fraud or concealment shall survive indefinitely.

(l) Breach. Any material breach of the representations, warranties, or covenants set forth in this Section 12 shall constitute a material breach of this Agreement and shall entitle the non-breaching Party to pursue all available remedies at law or in equity.

(m) Condition Precedent to Chardan and DBC’s Obligations. DBC and Chardan’s execution of this Agreement is expressly conditioned upon the truth and accuracy of the representations and warranties set forth in this Section 12 as of the date hereof.

13. No Admission of Wrongdoing or Liability; No Use Upon Termination

Each Party to this Agreement expressly denies the material allegations asserted against it by the other Parties. By entering into this Agreement, no Party admits to any wrongdoing or liability of any kind whatsoever. The Parties acknowledge and agree that the terms of this Agreement reflect a negotiated compromise of disputed claims and that nothing contained herein shall be presented or construed as an admission or concession of wrongdoing or liability of any kind whatsoever by any Party. The Parties further acknowledge that this no-admission provision has no bearing on the authority of any governmental or regulatory body, including the Commission or FINRA, to investigate or take action with respect to any underlying conduct. Notwithstanding anything to the contrary contained herein, in the event that this Agreement is terminated in accordance with its terms, neither this Agreement, nor any of its provisions, nor any negotiations, discussions, or communications relating hereto, nor any disclosure, filing, or statement contained in or made in connection with any registration statement, prospectus, or other offering document referencing or incorporating this Settlement Agreement, shall be admissible in evidence or used for any purpose in any action, suit, arbitration, or other proceeding between or among the Parties; provided, however, that this Section shall not prohibit the use of such materials solely to the extent necessary to enforce the express terms of this Section or to establish the fact of termination of this Agreement.

Page 10 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

14. Taxes, Costs, Fees, and Expenses

Each Party shall be responsible for its own taxes, costs, fees, expenses, and attorneys’ fees incurred in connection with this Agreement, the Arbitration, and the Special Proceeding.

15. Sole Consideration

The Parties understand and agree that the consideration recited in this Agreement is the sole and only consideration for this Agreement, and that no other consideration has been paid or promised in connection herewith.

16. Entire Agreement; Limited Supersession

This Agreement, together with the Underwriting Agreement and the IPO Engagement Letter, constitutes the entire agreement and understanding of the Parties with respect to the subject matter expressly set forth herein, and supersedes all prior and contemporaneous agreements, negotiations, understandings, and discussions, whether written or oral, relating to such subject matter. Notwithstanding the foregoing:

(a) The Legacy Agreements are not superseded, terminated, or modified by this Agreement and shall remain in full force and effect in accordance with their terms unless and until the Effective Time, at which time they shall automatically terminate pursuant to Section 10 without further action by any Party.

(b) The Underwriting Agreement and the IPO Engagement Letter shall remain in full force and effect in accordance with their respective terms and are not superseded, modified, or amended by this Agreement except to the extent expressly set forth herein.

(c) For the avoidance of doubt: (i) the Legacy Agreements shall continue in effect as provided above until such termination; and (ii) the termination of the Legacy Agreements shall not affect any rights or claims arising thereunder prior to such termination that are not otherwise released pursuant to Section 11.

17. Modifications

This Agreement may not be modified or amended orally or in any other manner unless in writing and duly signed by authorized representatives of all Parties.

18. Negotiated Agreement

Each Party acknowledges and agrees that the terms and conditions of this Agreement are the result of arm’s-length negotiation between and among the Parties and their respective counsel, and agrees that this Agreement shall not be construed in favor of or against any Party by reason of the extent to which any Party or its respective counsel participated in its drafting.

Page 11 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

19. Confidentiality and Disclosure Obligations

(a) Each of the Parties agrees not to voluntarily disclose, directly or indirectly, the terms and conditions of this Agreement to any third party, except as necessary to enforce the Agreement, including, but not limited to, in any dispute arising out of this Agreement.

(b) Notwithstanding Section 19(a), the Parties may disclose the terms of this Agreement on an as-needed basis to their respective attorneys, accountants, auditors, and tax consultants who are bound by confidentiality obligations no less restrictive than those contained herein.

(c) Nothing in this Agreement shall prevent any Party from making any disclosure required:

(i) to comply with any validly issued subpoena or other legal or judicial process issued by any court, legislative, or regulatory body of competent jurisdiction;

(ii) in connection with a registration statement, prospectus, filing with FINRA, the Commission, or any other self-regulatory organization or federal or state authority, including without limitation any disclosure required under applicable securities laws, FINRA rules, or Commission regulations or comments;

(iii) to comply with any reporting obligation imposed by FINRA Rule 4530 or any other applicable FINRA rule;

(iv) to communicate with, provide information to, or cooperate with any governmental, regulatory, or self-regulatory organization, including without limitation the Commission, FINRA, or any state securities regulator, in connection with any inquiry, investigation, examination, or proceeding, whether voluntary or compelled; or

(v) pursuant to the whistleblower protection provisions of Section 21F of the Exchange Act, SEC Rule 21F-17, or any applicable FINRA rule, including FINRA Rule 2010, it being the express intent of the Parties that no provision of this Agreement shall be construed to impede, restrict, or condition any Party’s right to communicate directly with the Commission or FINRA staff about a possible securities law violation.

(d) The Parties expressly acknowledge that this Agreement does not limit any Party’s obligation to disclose material information required under applicable securities laws in connection with any securities offering or reporting obligation.

20. Severability

It is intended that the terms and provisions of this Agreement are severable. To the extent that any term or provision hereof is held to be void, invalid, illegal, or unenforceable in any respect by a court or arbitral tribunal of competent jurisdiction, the remainder of this Agreement and the Releases shall not be affected thereby and shall be valid and enforceable to the fullest extent permitted by law.

Page 12 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

21. No Waiver

No provision of this Agreement shall be waived except by a writing signed by the Party waiving same, and only to the extent so specified in that writing. No waiver of any provision of this Agreement shall be deemed to constitute a waiver or modification of any other provision, nor shall any such waiver constitute a continuing waiver.

22. Reliance on Own Counsel

Each Party hereby acknowledges and agrees that it has had the opportunity to review this Agreement and consult with legal counsel of its choice prior to execution, and has in fact done so, and has been specifically advised by its counsel of the consequences of this Agreement and its respective rights and obligations hereunder. Each Party further acknowledges and agrees that it is relying solely on the advice of its own legal counsel with respect to this Agreement.

23. Standstill

(a) From the date of this Agreement until the earlier of (i) the Effective Time and (ii) the termination of this Agreement pursuant to Section 4 (the “Standstill Period”), each Party agrees that it shall not, and shall cause its affiliates, representatives, attorneys, and agents not to, directly or indirectly:

(i) commence, assert, or prosecute any private claim, action, arbitration, or proceeding against any other Party arising out of or relating to the Legacy Agreements or the subject matter of the dispute between the Parties;

(ii) take any action, or omit to take any action, with the intent or the reasonably foreseeable effect of materially interfering with, delaying, or impairing the IPO; or

(iii) make or publish any public statement or communication that is materially false or misleading and that is intended to disparage or that is reasonably likely to materially and adversely affect the reputation, business, or prospects of any other Party.

(b) Notwithstanding Section 23(a), nothing herein shall prohibit any Party from:

(i) enforcing the terms of this Agreement or asserting claims arising from a breach of this Agreement;

(ii) asserting claims based on fraud, fraudulent inducement, intentional misrepresentation, or the knowing concealment or nondisclosure of material facts; or

(iii) taking any action expressly permitted or required by Section 19(c) of this Agreement, including without limitation communicating with governmental or regulatory authorities, making required disclosures in the IPO registration statement, or exercising whistleblower rights under applicable law.

Page 13 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

(c) Remedies. The Parties agree that this Section 23 is a material inducement to entering into this Agreement and that any breach shall result in irreparable harm entitling the non-breaching Party to seek injunctive relief, specific performance, and any other available equitable remedies in a court of competent jurisdiction, without the requirement to post a bond; provided, however, that no such equitable relief shall be available to restrict any activity described in Section 23(b).

24. Governing Law, Jurisdiction, and Jury Trial Waiver

(a) This Agreement, including the Releases, shall be construed under and governed by the laws of the State of New York, without giving effect to any choice-of-law or conflicts-of-law principles that would otherwise require the application of the laws of a different jurisdiction.

(b) Any action arising out of or relating to this Agreement and/or the Releases shall be brought exclusively in the state courts of the State of New York sitting in New York County, or the United States District Court for the Southern District of New York, and each Party irrevocably submits to the personal jurisdiction of such courts and waives any objection to venue, including any claim of forum non conveniens.

(c) EACH PARTY HEREBY KNOWINGLY, VOLUNTARILY, AND INTENTIONALLY WAIVES ANY RIGHT IT OR HE MAY HAVE TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING, OR CLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT AND/OR THE RELEASES. EACH PARTY ACKNOWLEDGES THAT THIS JURY TRIAL WAIVER IS A MATERIAL INDUCEMENT TO THE OTHER PARTIES TO ENTER INTO THIS AGREEMENT. EACH PARTY REPRESENTS THAT IT OR HE HAS REVIEWED THIS WAIVER WITH LEGAL COUNSEL AND THAT THE DECISION TO WAIVE JURY TRIAL IS MADE KNOWINGLY AND VOLUNTARILY.

(d) In the event that any Party (an “Initiating Party”) brings suit, an arbitration, or otherwise attempts to pursue any claim or right or to enforce any remedy against any other Party with respect to a claim that has been released under Section 11 (a “Released Claim”), the responding Party or Parties shall be entitled to recover from the Initiating Party all damages, losses, costs, and expenses, including reasonable attorneys’ fees and court costs, arising out of or relating to the pursuit of such Released Claim, and the Initiating Party’s release shall be automatically deemed null and void and of no further force or effect. Notwithstanding the foregoing, any rights or remedies available under the Underwriting Agreement or this Agreement shall not be considered a Released Claim.

25. Counterparts

This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same Agreement binding on all Parties.

26. Electronic Execution; Authoritative Copy; Cross-Border Enforceability

The Parties agree that this Agreement and any related documents may be executed and delivered by electronic signature (including, without limitation, by DocuSign, Adobe Sign, or other similar electronic signature platforms), and that any such electronic signatures shall be deemed to have the same legal effect as original handwritten signatures for all purposes. This Agreement may be executed in counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument.

Page 14 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

The Parties further agree that the electronic version of this Agreement maintained by the electronic signature platform used to execute this Agreement shall constitute the “authoritative copy” of this Agreement for all purposes, including for evidentiary use in any judicial, arbitral, regulatory, or administrative proceeding. Each Party agrees not to contest the admissibility or enforceability of such authoritative copy or any electronic record of this Agreement (including PDF or other imaged formats) on the basis that it is not a paper original, provided that such record remains accessible for subsequent reference.

The Parties acknowledge and agree that the execution and delivery of this Agreement by electronic means is intended to comply with applicable electronic signature and record laws, including, without limitation, the Electronic Signatures in Global and National Commerce Act (15 U.S.C. § 7001 et seq.), the New York Electronic Signatures and Records Act (N.Y. State Technology Law §§ 301–309), Regulation (EU) No 910/2014 (eIDAS), as applicable in Greece, and the Electronic Transactions Act (As Revised) of the Cayman Islands, together with any analogous laws in other relevant jurisdictions. Each Party agrees that it will not challenge the validity or enforceability of this Agreement on the basis that it was executed electronically or across national borders, except to the extent such challenge cannot be waived under applicable law.

Notwithstanding the foregoing, each Party acknowledges that this Agreement, and any electronic execution hereof, may be referenced, summarized, or disclosed in any registration statement, prospectus, or other filing with the U.S. Securities and Exchange Commission or any securities exchange, including Nasdaq, to the extent required by applicable law, regulation, or exchange rules. No provision of this Section shall be construed to limit or restrict compliance with applicable disclosure obligations, including those arising under the Securities Act of 1933, the Securities Exchange Act of 1934, or FINRA rules (including Rule 5110), or to impair the ability of any Party or its affiliates to retain and produce this Agreement or related electronic records in connection with due diligence, regulatory review, or any inquiry by the SEC, FINRA, or any other governmental or self-regulatory authority.

The Parties further agree that the use of electronic signatures and maintenance of an authoritative copy as provided herein is consistent with commercially reasonable practices for evidencing agreements in capital markets transactions and is intended to support the reliability, integrity, and reproducibility of records for purposes of legal enforceability, regulatory compliance, and due diligence review.

27. Authority to Execute Agreement

By signing below, each Party warrants and represents that the person signing this Agreement on its behalf has full authority to bind that Party and that the Party’s execution of this Agreement is not in violation of any by-law, covenant, operating agreement, resolution, or other restriction applicable to that Party.

Page 15 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

SIGNATURE PAGE

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first stated above.

CHARDAN CAPITAL MARKETS, LLC

By:

Name: 

Title:

Date:

DEMETRIOS MALLIOS, individually

Date:

AEON GROUP, INC.

By:

Name:

Title:

Date:

AEON ACQUISITION I CORP.

By:

Name:

Title:

Date:

GENESHIPS ACQUISITION CORP.

By Demetrios Mallios

By:

Name:

Title:

Date:

D. BORAL CAPITAL LLC

By:

Name:

Title:

Date:

Page 16 of 17

CONFIDENTIAL DRAFT SETTLEMENT AGREEMENT – SUBJECT TO FRE 408 AND CPLR 4547

EXHIBIT 1

(FORM OF UNDERWRITING AGREEMENT)

Page 17 of 17

EX-21.1

Exhibit 21.1

List of Subsidiaries

None.

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Demetrios Mallios, certify that:

1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2025 of Aeon Acquisition I Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 14, 2026	By:	/s/ Demetrios Mallios
		Demetrios Mallios
		Chief Executive Officer and Director
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Alan Lewis, certify that:

1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2025 of Aeon Acquisition I Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 14, 2026	By:	/s/ Alan Lewis
		Alan Lewis
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Aeon Acquisition I Corp. (the “Company”) on Form 10-K for the year ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 14, 2026	By:	/s/ Demetrios Mallios
		Demetrios Mallios
		Chief Executive Officer and Director
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Aeon Acquisition I Corp. (the “Company”) on Form 10-K for the year ended December 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 14, 2026	By:	/s/ Alan Lewis
		Alan Lewis
		Chief Financial Officer
		(Principal Financial and Accounting Officer)